| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | signal sequence binding | 3.06e-07 | 51 | 176 | 7 | GO:0005048 | |
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 2.31e-06 | 25 | 176 | 5 | GO:0017056 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 3.47e-06 | 27 | 176 | 5 | GO:0008139 | |
| GeneOntologyMolecularFunction | transcription factor binding | FLNA PCLO NSD1 BBS4 TACC2 KDM5D ZFPM2 YEATS2 NCOR1 ARID2 FOXP1 MYOCD NR3C2 PARP9 PRKDC SUZ12 HCFC1 TP53BP2 HTT | 3.85e-05 | 753 | 176 | 19 | GO:0008134 |
| GeneOntologyMolecularFunction | transcription coregulator activity | SUPT20HL1 MED10 MAGED1 NUP98 NSD1 SUPT20HL2 ZFPM2 YEATS2 NCOR1 KMT2C KMT2D ARID5B MYOCD PARP9 HCFC1 MRTFA | 3.96e-05 | 562 | 176 | 16 | GO:0003712 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | SUPT20HL1 MED10 MAGED1 ATG2B NUP98 NSD1 BBS4 SUPT20HL2 ZFPM2 MAPK8IP3 YEATS2 NCOR1 RGS14 KMT2C KMT2D ARID5B TNRC6A AKAP13 MYOCD PARP9 ZNF598 HCFC1 NUP153 MRTFA | 8.61e-05 | 1160 | 176 | 24 | GO:0030674 |
| GeneOntologyMolecularFunction | U3 snoRNA binding | 1.05e-04 | 11 | 176 | 3 | GO:0034511 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | SUPT20HL1 MED10 MAGED1 ATG2B NUP98 NSD1 BBS4 SUPT20HL2 ZFPM2 MAPK8IP3 YEATS2 NCOR1 RGS14 KMT2C KMT2D PDE4DIP ARID5B TNRC6A AKAP13 MYOCD PARP9 ZNF598 HCFC1 NUP153 MRTFA | 3.61e-04 | 1356 | 176 | 25 | GO:0060090 |
| GeneOntologyBiologicalProcess | protein localization to nucleus | FLNA RANBP2 MAGED1 UACA NUP98 BBS4 POM121C UTP25 GLI3 NPAP1 PARP9 POM121B NUP153 HTT | 2.91e-06 | 362 | 176 | 14 | GO:0034504 |
| GeneOntologyBiologicalProcess | microtubule-based process | LCA5 FLNA SPEM3 KIF26B APC BBS4 PEX13 APOB TACC2 EYA1 ATAT1 LYST MAPK8IP3 NCOR1 RGS14 ARL3 BRCA2 NISCH PDE4DIP CCSER2 SASS6 DIXDC1 CEP126 HYDIN HTT | 3.75e-06 | 1058 | 176 | 25 | GO:0007017 |
| GeneOntologyBiologicalProcess | protein localization to organelle | FLNA RANBP2 MAGED1 UACA KALRN NUP98 APC BBS4 PEX13 SRPRA NBEA PEX5L POM121C ARL3 UTP25 BRCA2 AIFM1 GLI3 SCARB2 NPAP1 PARP9 SPIDR POM121B NUP153 HTT | 6.41e-06 | 1091 | 176 | 25 | GO:0033365 |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | FLNA RANBP2 UACA NUP98 PEX13 SRPRA PEX5L POM121C BRCA2 AIFM1 GLI3 SCARB2 NPAP1 SPIDR POM121B NUP153 | 9.23e-06 | 515 | 176 | 16 | GO:0072594 |
| GeneOntologyBiologicalProcess | nuclear pore organization | 1.43e-05 | 18 | 176 | 4 | GO:0006999 | |
| GeneOntologyBiologicalProcess | neuron development | FLNA SLC4A7 FN1 TRIO KALRN NEUROD4 DPYSL5 APC BBS4 PAK6 ATAT1 MFRP MAPK8IP3 GDPD5 ARL3 PLAA PLPPR4 ATXN2 PTPRZ1 GLI3 CLN5 SCARB2 TET1 UNC5C KCNMA1 FOXP1 DIXDC1 MRTFA HTT | 1.76e-05 | 1463 | 176 | 29 | GO:0048666 |
| GeneOntologyBiologicalProcess | central nervous system development | FLNA SLC4A7 NEUROD4 BBS4 PEX13 TACC2 ATAT1 MAPK8IP3 PITPNM1 GDPD5 NCOR1 PTPRJ BRCA2 ATXN2 PTPRZ1 GLI3 UNC5C FOXP1 DIXDC1 PRKDC SUZ12 HYDIN MRTFA TP53BP2 HTT | 3.07e-05 | 1197 | 176 | 25 | GO:0007417 |
| GeneOntologyBiologicalProcess | head development | FLNA SLC4A7 BBS4 PEX13 TACC2 ATAT1 MAPK8IP3 PITPNM1 GDPD5 NCOR1 BRCA2 ATXN2 GLI3 UNC5C ARID5B FOXP1 DIXDC1 PRKDC HYDIN MRTFA HTT | 3.92e-05 | 919 | 176 | 21 | GO:0060322 |
| GeneOntologyBiologicalProcess | brain development | FLNA SLC4A7 BBS4 PEX13 TACC2 ATAT1 MAPK8IP3 PITPNM1 GDPD5 NCOR1 BRCA2 ATXN2 GLI3 UNC5C FOXP1 DIXDC1 PRKDC HYDIN MRTFA HTT | 4.68e-05 | 859 | 176 | 20 | GO:0007420 |
| GeneOntologyBiologicalProcess | protein import into nucleus | 4.68e-05 | 195 | 176 | 9 | GO:0006606 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | DMTF1 ATMIN SUPT20HL1 MED10 HIVEP1 NEUROD4 SUPT20HL2 ZNF395 POGZ EYA1 RFX7 ZFPM2 KMT2C KMT2D ELL2 ZBED4 CDK13 GLI3 ARID2 TET1 NLRC5 FOXP1 MYOCD NR3C2 PRKDC HCFC1 MRTFA | 5.05e-05 | 1390 | 176 | 27 | GO:0045944 |
| GeneOntologyBiologicalProcess | positive regulation of neuron migration | 5.63e-05 | 25 | 176 | 4 | GO:2001224 | |
| GeneOntologyBiologicalProcess | import into nucleus | 5.92e-05 | 201 | 176 | 9 | GO:0051170 | |
| GeneOntologyBiologicalProcess | embryo development | SUPT20HL1 FN1 SPEG NSD1 BBS4 SUPT20HL2 APOB EYA1 MFRP ZFPM2 MAPK8IP3 YEATS2 NCOR1 KMT2D UTP25 BRCA2 GLI3 ARID2 TET1 EIF2S2 FOXP1 ABCG2 PRKDC TDRD6 HCFC1 TP53BP2 HTT | 8.85e-05 | 1437 | 176 | 27 | GO:0009790 |
| GeneOntologyBiologicalProcess | subpallium development | 8.94e-05 | 28 | 176 | 4 | GO:0021544 | |
| GeneOntologyBiologicalProcess | nuclear transport | FLNA RANBP2 UACA CTDSPL2 NUP98 POM121C RGS14 GLI3 NPAP1 AKAP13 POM121B NUP153 | 1.02e-04 | 378 | 176 | 12 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | FLNA RANBP2 UACA CTDSPL2 NUP98 POM121C RGS14 GLI3 NPAP1 AKAP13 POM121B NUP153 | 1.02e-04 | 378 | 176 | 12 | GO:0006913 |
| GeneOntologyBiologicalProcess | developmental growth | VIL1 FN1 KIF26B APC BBS4 PAK6 ZFPM2 NCOR1 KMT2C KMT2D PLAA BRCA2 ATXN2 GLI3 ARID2 ARID5B FOXP1 AKAP13 MYOCD PRKDC | 1.05e-04 | 911 | 176 | 20 | GO:0048589 |
| GeneOntologyBiologicalProcess | organelle assembly | ATMIN VIL1 FLNA GARIN1A ATG2B BBS4 POGZ ATAT1 NCOR1 WDR45 ARL3 ATXN2 PRRC2C NISCH CSRP1 TNRC6A SASS6 AKAP13 PRKDC CEP126 HYDIN RUFY4 HTT | 1.07e-04 | 1138 | 176 | 23 | GO:0070925 |
| GeneOntologyBiologicalProcess | neuron migration | 1.10e-04 | 218 | 176 | 9 | GO:0001764 | |
| GeneOntologyBiologicalProcess | RNA transport | 1.33e-04 | 175 | 176 | 8 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 1.33e-04 | 175 | 176 | 8 | GO:0050657 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | FLNA GARIN1A SPEM3 ANGPT2 APC BBS4 APOB ATAT1 ZFPM2 SLC4A2 KMT2D IGF2R BRCA2 TESK2 UNC5C EIF2S2 ARID5B NPAP1 MYOCD PRKDC TDRD6 AFF4 ALOX15B HTT | 1.37e-04 | 1235 | 176 | 24 | GO:0003006 |
| GeneOntologyBiologicalProcess | artery development | 1.47e-04 | 133 | 176 | 7 | GO:0060840 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 1.49e-04 | 178 | 176 | 8 | GO:0051236 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | FLNA APC BBS4 TACC2 EYA1 ATAT1 NCOR1 RGS14 BRCA2 NISCH PDE4DIP CCSER2 SASS6 DIXDC1 CEP126 HYDIN HTT | 1.51e-04 | 720 | 176 | 17 | GO:0000226 |
| GeneOntologyBiologicalProcess | regulation of neuron migration | 1.87e-04 | 62 | 176 | 5 | GO:2001222 | |
| GeneOntologyBiologicalProcess | nuclear export | 1.94e-04 | 185 | 176 | 8 | GO:0051168 | |
| GeneOntologyBiologicalProcess | forebrain development | FLNA BBS4 PEX13 TACC2 ATAT1 MAPK8IP3 GDPD5 NCOR1 GLI3 FOXP1 DIXDC1 MRTFA HTT | 3.03e-04 | 489 | 176 | 13 | GO:0030900 |
| GeneOntologyBiologicalProcess | growth | VIL1 CDKN2D FN1 KIF26B APC BBS4 PAK6 ZFPM2 NCOR1 KMT2C KMT2D PLAA PTPRJ BRCA2 ATXN2 GLI3 ARID2 ARID5B FOXP1 AKAP13 MYOCD PRKDC ALOX15B | 3.51e-04 | 1235 | 176 | 23 | GO:0040007 |
| GeneOntologyBiologicalProcess | platelet-derived growth factor receptor signaling pathway | 3.53e-04 | 71 | 176 | 5 | GO:0048008 | |
| GeneOntologyBiologicalProcess | calcium-independent cell-matrix adhesion | 4.30e-04 | 4 | 176 | 2 | GO:0007161 | |
| GeneOntologyBiologicalProcess | protein import into peroxisome matrix, docking | 4.30e-04 | 4 | 176 | 2 | GO:0016560 | |
| GeneOntologyBiologicalProcess | regulation of neutrophil differentiation | 4.30e-04 | 4 | 176 | 2 | GO:0045658 | |
| GeneOntologyBiologicalProcess | regulation of non-motile cilium assembly | 4.54e-04 | 18 | 176 | 3 | GO:1902855 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | ATMIN VIL1 FLNA APC BBS4 ATAT1 PLEKHM1 WDR45 LRRN3 PTPRJ PDE4DIP SASS6 SPIDR HTT | 4.87e-04 | 582 | 176 | 14 | GO:0044089 |
| GeneOntologyBiologicalProcess | renal system development | DCHS2 MAGED1 ANGPT2 KIF26B APC EYA1 ARL3 GLI3 ARID5B MYOCD ENPEP | 4.99e-04 | 386 | 176 | 11 | GO:0072001 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | JCAD FLNA RANBP2 UACA KALRN PCLO APC PEX5L MAPK8IP3 GDPD5 NCOR1 IGF2R GBP4 ATXN2 AIFM1 CLN5 TNRC6A KCNMA1 AKAP13 TP53BP2 HTT | 4.45e-05 | 934 | 177 | 21 | GO:0048471 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TTF2 FLNA RANBP2 MED10 INTS12 ZCCHC8 SCAF8 NUP98 NSD1 POM121C NCOR1 KMT2C KMT2D ELL2 BRCA2 CDK13 ARID2 TET1 NPAP1 MYOCD PRKDC SUZ12 POM121B HCFC1 NUP153 AFF4 | 9.94e-05 | 1377 | 177 | 26 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear pore | 2.21e-04 | 101 | 177 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 4.40e-04 | 75 | 177 | 5 | GO:0035097 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 4.44e-04 | 18 | 177 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 6.12e-04 | 20 | 177 | 3 | GO:0042405 | |
| MousePheno | abnormal neuron physiology | CDKN2D MAGED1 TRIO KALRN DPYSL5 PEX5L MAPK8IP3 GDPD5 RGS14 PLAA AIFM1 GLI3 SCARB2 TET1 UNC5C CCSER2 KCNMA1 TP53BP2 HTT | 3.62e-05 | 604 | 154 | 19 | MP:0004811 |
| MousePheno | abnormal cardiovascular development | ATMIN JCAD SUPT20HL1 FLNA ANGPT2 FN1 SPEG UBR4 APC SUPT20HL2 EYA1 ZFPM2 IGF2R PTPRJ GLI3 ARID2 SASS6 FOXP1 AKAP13 MYOCD MRTFA TP53BP2 | 6.72e-05 | 802 | 154 | 22 | MP:0002925 |
| MousePheno | abnormal embryonic growth/weight/body size | SUPT20HL1 ACACA FN1 TRIO UBR4 NUP98 APC NBEA SUPT20HL2 APOB CLCC1 NCOR1 IGF2R PTPRJ BRCA2 PIK3C2A ADAMTS9 AIFM1 CDK13 PRRC2C GLI3 TET1 SASS6 AKAP13 MYOCD SUZ12 HCFC1 AFF4 HTT KLB | 6.80e-05 | 1295 | 154 | 30 | MP:0002088 |
| MousePheno | abnormal temporal memory | 6.80e-05 | 239 | 154 | 11 | MP:0001468 | |
| MousePheno | prenatal lethality, incomplete penetrance | SUPT20HL1 FN1 APC BBS4 SUPT20HL2 APOB POGZ ZFPM2 MEP1B KMT2C ARL3 PTPRJ BRCA2 ATXN2 AIFM1 GLI3 TET1 TNRC6A AFF4 MRTFA HTT | 7.06e-05 | 747 | 154 | 21 | MP:0011101 |
| MousePheno | embryonic lethality during organogenesis | ACACA FN1 UBR4 NSD1 APC BBS4 APOB POGZ ZFPM2 KMT2D PTPRJ BRCA2 ADAMTS9 AIFM1 GLI3 ARID2 TET1 TNRC6A AKAP13 MYOCD SUZ12 AFF4 HTT | 8.79e-05 | 876 | 154 | 23 | MP:0006207 |
| MousePheno | abnormal cerebral hemisphere morphology | SP4 TRIO KALRN BBS4 PEX13 POGZ ATAT1 LYST MAPK8IP3 KMT2D PLAA GLI3 CCSER2 SUZ12 HCFC1 HYDIN TP53BP2 HTT | 1.06e-04 | 599 | 154 | 18 | MP:0008540 |
| MousePheno | abnormal ocular fundus morphology | JCAD SUPT20HL1 LCA5 SLC4A7 ANGPT2 ATG2B BMS1 AAK1 BBS4 SUPT20HL2 ZNF395 RFX7 MFRP POM121C LYST PLEKHM1 CLCC1 WDR45 ARL3 ELL2 HMCN1 AIFM1 GLI3 PDE4DIP AKAP13 DIXDC1 KLK13 POM121B TP53BP2 | 1.06e-04 | 1262 | 154 | 29 | MP:0002864 |
| MousePheno | abnormal right lung middle lobe morphology | 1.21e-04 | 2 | 154 | 2 | MP:0009573 | |
| MousePheno | enlarged tectum | 1.21e-04 | 2 | 154 | 2 | MP:0009048 | |
| MousePheno | abnormal embryo size | ACACA FN1 TRIO UBR4 NUP98 APC NBEA APOB CLCC1 NCOR1 IGF2R PTPRJ BRCA2 PIK3C2A ADAMTS9 AIFM1 CDK13 PRRC2C GLI3 SASS6 SUZ12 HCFC1 HTT KLB | 1.22e-04 | 956 | 154 | 24 | MP:0001697 |
| MousePheno | abnormal gastrulation movements | 1.49e-04 | 10 | 154 | 3 | MP:0002174 | |
| MousePheno | abnormal prenatal growth/weight/body size | ATMIN SUPT20HL1 ACACA FN1 TRIO UBR4 NUP98 APC NBEA SUPT20HL2 APOB POGZ CLCC1 NCOR1 IGF2R PTPRJ BRCA2 PIK3C2A ADAMTS9 AIFM1 CDK13 PRRC2C GLI3 TET1 SASS6 AKAP13 MYOCD SUZ12 HCFC1 AFF4 HTT KLB | 1.62e-04 | 1493 | 154 | 32 | MP:0004196 |
| MousePheno | abnormal prenatal body size | ATMIN ACACA FN1 TRIO UBR4 NUP98 APC NBEA APOB POGZ CLCC1 NCOR1 IGF2R PTPRJ BRCA2 PIK3C2A ADAMTS9 AIFM1 CDK13 PRRC2C GLI3 SASS6 SUZ12 HCFC1 HTT KLB | 2.05e-04 | 1116 | 154 | 26 | MP:0010866 |
| Domain | Znf_FYVE_PHD | 6.34e-05 | 147 | 171 | 8 | IPR011011 | |
| Domain | PHD | 6.44e-05 | 75 | 171 | 6 | PF00628 | |
| Domain | Znf_PHD-finger | 8.63e-05 | 79 | 171 | 6 | IPR019787 | |
| Domain | PHD | 1.67e-04 | 89 | 171 | 6 | SM00249 | |
| Domain | Znf_PHD | 1.89e-04 | 91 | 171 | 6 | IPR001965 | |
| Domain | ZF_PHD_2 | 2.39e-04 | 95 | 171 | 6 | PS50016 | |
| Domain | K_chnl_volt-dep_ERG | 2.49e-04 | 3 | 171 | 2 | IPR003967 | |
| Domain | ZF_PHD_1 | 2.53e-04 | 96 | 171 | 6 | PS01359 | |
| Domain | - | 3.16e-04 | 15 | 171 | 3 | 1.10.150.60 | |
| Domain | BRIGHT | 3.16e-04 | 15 | 171 | 3 | SM00501 | |
| Domain | ARID_dom | 3.16e-04 | 15 | 171 | 3 | IPR001606 | |
| Domain | ARID | 3.16e-04 | 15 | 171 | 3 | PS51011 | |
| Domain | ARID | 3.16e-04 | 15 | 171 | 3 | PF01388 | |
| Domain | Post-SET_dom | 3.87e-04 | 16 | 171 | 3 | IPR003616 | |
| Domain | PostSET | 3.87e-04 | 16 | 171 | 3 | SM00508 | |
| Domain | POST_SET | 3.87e-04 | 16 | 171 | 3 | PS50868 | |
| Domain | FYrich_C | 8.18e-04 | 5 | 171 | 2 | IPR003889 | |
| Domain | FYrich_N | 8.18e-04 | 5 | 171 | 2 | IPR003888 | |
| Domain | FYRC | 8.18e-04 | 5 | 171 | 2 | SM00542 | |
| Domain | FYRN | 8.18e-04 | 5 | 171 | 2 | SM00541 | |
| Domain | Anion_exchange | 8.18e-04 | 5 | 171 | 2 | IPR001717 | |
| Domain | FYRN | 8.18e-04 | 5 | 171 | 2 | PF05964 | |
| Domain | FYRC | 8.18e-04 | 5 | 171 | 2 | PF05965 | |
| Domain | FYRC | 8.18e-04 | 5 | 171 | 2 | PS51543 | |
| Domain | FYRN | 8.18e-04 | 5 | 171 | 2 | PS51542 | |
| Domain | CRAL_TRIO | 8.88e-04 | 21 | 171 | 3 | PF00650 | |
| Domain | ARM-type_fold | 1.16e-03 | 339 | 171 | 10 | IPR016024 | |
| Domain | - | 1.17e-03 | 23 | 171 | 3 | 3.40.525.10 | |
| Domain | PH_BEACH | 1.22e-03 | 6 | 171 | 2 | PF14844 | |
| Domain | SEC14 | 1.50e-03 | 25 | 171 | 3 | SM00516 | |
| Domain | FN3 | 1.60e-03 | 185 | 171 | 7 | SM00060 | |
| Domain | RPEL | 1.70e-03 | 7 | 171 | 2 | PS51073 | |
| Domain | RPEL | 1.70e-03 | 7 | 171 | 2 | SM00707 | |
| Domain | ANION_EXCHANGER_2 | 1.70e-03 | 7 | 171 | 2 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 1.70e-03 | 7 | 171 | 2 | PS00219 | |
| Domain | RPEL | 1.70e-03 | 7 | 171 | 2 | PF02755 | |
| Domain | RPEL_repeat | 1.70e-03 | 7 | 171 | 2 | IPR004018 | |
| Domain | CRAL_TRIO | 1.88e-03 | 27 | 171 | 3 | PS50191 | |
| Domain | CRAL-TRIO_dom | 2.09e-03 | 28 | 171 | 3 | IPR001251 | |
| Domain | PH-BEACH_dom | 2.25e-03 | 8 | 171 | 2 | IPR023362 | |
| Domain | - | 2.25e-03 | 8 | 171 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 2.25e-03 | 8 | 171 | 2 | PS51783 | |
| Domain | FN3 | 2.42e-03 | 199 | 171 | 7 | PS50853 | |
| Domain | TSP_1 | 2.65e-03 | 63 | 171 | 4 | PF00090 | |
| Domain | - | 2.88e-03 | 9 | 171 | 2 | 3.40.1100.10 | |
| Domain | BEACH | 2.88e-03 | 9 | 171 | 2 | PS50197 | |
| Domain | Beach | 2.88e-03 | 9 | 171 | 2 | PF02138 | |
| Domain | - | 2.88e-03 | 9 | 171 | 2 | 1.10.1540.10 | |
| Domain | Beach | 2.88e-03 | 9 | 171 | 2 | SM01026 | |
| Domain | Band3_cytoplasmic_dom | 2.88e-03 | 9 | 171 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 2.88e-03 | 9 | 171 | 2 | PF07565 | |
| Domain | BEACH_dom | 2.88e-03 | 9 | 171 | 2 | IPR000409 | |
| Domain | RFX_DNA_binding | 2.88e-03 | 9 | 171 | 2 | PF02257 | |
| Domain | DNA-bd_RFX | 2.88e-03 | 9 | 171 | 2 | IPR003150 | |
| Domain | RFX_DBD | 2.88e-03 | 9 | 171 | 2 | PS51526 | |
| Domain | TSP1 | 2.97e-03 | 65 | 171 | 4 | SM00209 | |
| Domain | TSP1_rpt | 2.97e-03 | 65 | 171 | 4 | IPR000884 | |
| Domain | TSP1 | 2.97e-03 | 65 | 171 | 4 | PS50092 | |
| Domain | FN3_dom | 3.18e-03 | 209 | 171 | 7 | IPR003961 | |
| Domain | PTrfase/Anion_transptr | 3.57e-03 | 10 | 171 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 3.57e-03 | 10 | 171 | 2 | IPR003020 | |
| Domain | HCO3_cotransp | 3.57e-03 | 10 | 171 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 3.57e-03 | 10 | 171 | 2 | IPR011531 | |
| Domain | PAS_9 | 3.57e-03 | 10 | 171 | 2 | PF13426 | |
| Domain | fn3 | 3.81e-03 | 162 | 171 | 6 | PF00041 | |
| Domain | ZnF_BED | 4.34e-03 | 11 | 171 | 2 | SM00614 | |
| Domain | ZINC_FINGER_C2H2_2 | ATMIN SP4 HIVEP1 ZNF395 POGZ GPATCH8 ZNF181 ZFPM2 ZSCAN32 ZFHX4 GLI3 ARID2 FOXP1 SUZ12 ZNF598 | 5.14e-03 | 775 | 171 | 15 | PS50157 |
| Domain | Znf_BED | 5.18e-03 | 12 | 171 | 2 | IPR003656 | |
| Domain | ZINC_FINGER_C2H2_1 | ATMIN SP4 HIVEP1 ZNF395 POGZ GPATCH8 ZNF181 ZFPM2 ZSCAN32 ZFHX4 GLI3 ARID2 FOXP1 SUZ12 ZNF598 | 5.26e-03 | 777 | 171 | 15 | PS00028 |
| Domain | Ig-like_fold | FLNA FN1 TRIO KALRN SPEG SIGLEC5 SLC4A2 LRRN3 HMCN1 PTPRJ PTPRZ1 UNC5C NCR2 HCFC1 | 5.53e-03 | 706 | 171 | 14 | IPR013783 |
| Domain | IGc2 | 6.00e-03 | 235 | 171 | 7 | SM00408 | |
| Domain | Ig_sub2 | 6.00e-03 | 235 | 171 | 7 | IPR003598 | |
| Domain | HTH_Tnp_Tc5 | 6.08e-03 | 13 | 171 | 2 | PF03221 | |
| Domain | - | 6.08e-03 | 13 | 171 | 2 | 2.10.10.10 | |
| Domain | SET | 6.23e-03 | 41 | 171 | 3 | PF00856 | |
| Domain | Znf_C2H2-like | ATMIN SP4 HIVEP1 ZNF395 POGZ GPATCH8 ZNF181 ZFPM2 ZSCAN32 ZFHX4 GLI3 ARID2 FOXP1 SUZ12 ZNF598 | 6.53e-03 | 796 | 171 | 15 | IPR015880 |
| Domain | FN_type2_col-bd | 7.05e-03 | 14 | 171 | 2 | IPR000562 | |
| Domain | FN2_2 | 7.05e-03 | 14 | 171 | 2 | PS51092 | |
| Domain | FN2_1 | 7.05e-03 | 14 | 171 | 2 | PS00023 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 7.05e-03 | 14 | 171 | 2 | IPR003938 | |
| Domain | fn2 | 7.05e-03 | 14 | 171 | 2 | PF00040 | |
| Domain | FN2 | 7.05e-03 | 14 | 171 | 2 | SM00059 | |
| Domain | ZnF_C2H2 | ATMIN SP4 HIVEP1 ZNF395 POGZ GPATCH8 ZNF181 ZFPM2 ZSCAN32 ZFHX4 GLI3 ARID2 FOXP1 SUZ12 ZNF598 | 7.45e-03 | 808 | 171 | 15 | SM00355 |
| Domain | PI3/4_kinase_CS | 8.09e-03 | 15 | 171 | 2 | IPR018936 | |
| Domain | - | FLNA FN1 TRIO KALRN SPEG SIGLEC5 LRRN3 HMCN1 PTPRJ PTPRZ1 UNC5C NCR2 HCFC1 | 8.11e-03 | 663 | 171 | 13 | 2.60.40.10 |
| Domain | Ig_I-set | 8.17e-03 | 190 | 171 | 6 | IPR013098 | |
| Domain | I-set | 8.17e-03 | 190 | 171 | 6 | PF07679 | |
| Domain | SET | 8.58e-03 | 46 | 171 | 3 | SM00317 | |
| Domain | Pkinase | 8.60e-03 | 381 | 171 | 9 | PF00069 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 2.68e-06 | 41 | 138 | 6 | MM15200 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 7.81e-06 | 49 | 138 | 6 | MM14837 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 4.06e-05 | 65 | 138 | 6 | MM15147 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 4.18e-05 | 40 | 138 | 5 | MM14945 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 5.32e-05 | 42 | 138 | 5 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 5.97e-05 | 43 | 138 | 5 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 9.22e-05 | 47 | 138 | 5 | MM14939 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.24e-04 | 50 | 138 | 5 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.37e-04 | 51 | 138 | 5 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.96e-04 | 55 | 138 | 5 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 2.53e-04 | 58 | 138 | 5 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 2.53e-04 | 58 | 138 | 5 | MM14736 | |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 2.56e-04 | 32 | 138 | 4 | M29579 | |
| Pathway | REACTOME_SUMOYLATION | 2.56e-04 | 169 | 138 | 8 | MM14919 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 2.89e-04 | 33 | 138 | 4 | M27016 | |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 3.25e-04 | 34 | 138 | 4 | M27041 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | NSD1 KDM5D YEATS2 NCOR1 KMT2C KMT2D ARID2 ARID5B SUZ12 HCFC1 | 3.43e-04 | 272 | 138 | 10 | M29619 |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 3.64e-04 | 35 | 138 | 4 | M27320 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 4.06e-04 | 36 | 138 | 4 | M26974 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 4.06e-04 | 36 | 138 | 4 | M27245 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 4.31e-04 | 65 | 138 | 5 | M39682 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 4.52e-04 | 37 | 138 | 4 | M1029 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 4.52e-04 | 37 | 138 | 4 | M27038 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 5.54e-04 | 39 | 138 | 4 | M27238 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 6.48e-04 | 71 | 138 | 5 | M27394 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 6.72e-04 | 41 | 138 | 4 | M29574 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 7.36e-04 | 73 | 138 | 5 | MM14948 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 7.37e-04 | 42 | 138 | 4 | M48018 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 8.07e-04 | 43 | 138 | 4 | M26975 | |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 8.81e-04 | 44 | 138 | 4 | M109 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.04e-03 | 46 | 138 | 4 | M27397 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.13e-03 | 47 | 138 | 4 | M27395 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.25e-03 | 82 | 138 | 5 | MM15394 | |
| Pubmed | FKBP15 RANBP2 ARHGAP24 MAGED1 UACA TRIO KALRN UBR4 AAK1 NSD1 APC NBEA PEX5L MAPK8IP3 NCOR1 WDR45 IGF2R PLPPR4 ATXN2 PRRC2C NISCH PDE4DIP KCNMA1 ELAVL3 DIXDC1 WNK2 NUP153 AFF4 TP53BP2 | 2.95e-14 | 963 | 182 | 29 | 28671696 | |
| Pubmed | FLNA RANBP2 HIVEP1 ACACA ZCCHC8 UBR4 ATG2B APC POGZ YEATS2 NCOR1 KMT2D ZFHX4 BRCA2 TET1 ARID5B TNRC6A FOXP1 MRTFA TP53BP2 | 9.38e-14 | 418 | 182 | 20 | 34709266 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ATMIN FLNA CRYBG2 ACACA TRIO KALRN SPEG UBR4 NSD1 ARHGAP17 TWNK ZNF395 POM121C LYST PLEKHM1 MAPK8IP3 GDPD5 NCOR1 KMT2C KMT2D IGF2R ZBED4 CDK13 NISCH NLRC5 AKAP13 PRKDC HCFC1 WNK2 HTT | 1.47e-13 | 1105 | 182 | 30 | 35748872 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | DMTF1 PRUNE2 JCAD SP4 MAGED1 CTDSPL2 INPP5D UBR4 NUP98 KDM5D POM121C NCOR1 ATXN2 ARID2 AKAP13 WNK2 NUP153 MRTFA TP53BP2 | 1.63e-12 | 430 | 182 | 19 | 35044719 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | JCAD HIVEP1 SLC4A7 INTS12 ACACA TRIO KIF26B ZCCHC8 DPYSL5 AAK1 APC ARHGAP17 PAK6 RFX7 ATAT1 LYST PIK3C2A PRRC2C TESK2 TET1 CCSER2 AKAP13 NR3C2 ZNF598 TP53BP2 | 4.57e-12 | 861 | 182 | 25 | 36931259 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | JCAD TTF2 HIVEP1 VRK3 PCLO APC POGZ ZFPM2 YEATS2 KMT2C KMT2D ZFHX4 ARID2 ARID5B FOXP1 PRKDC SUZ12 | 4.33e-11 | 398 | 182 | 17 | 35016035 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FLNA RANBP2 HIVEP1 ACACA UACA ZCCHC8 SCAF8 NUP98 AAK1 POGZ GPATCH8 RFX7 MAPK8IP3 PITPNM1 YEATS2 NCOR1 KMT2D CDK13 PRKDC SUZ12 NUP153 MRTFA | 1.45e-10 | 774 | 182 | 22 | 15302935 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | TTF2 RANBP2 MED10 INTS12 VRK3 CTDSPL2 BAZ2B ZCCHC8 NUP98 NSD1 SRPRA ZNF395 POGZ GPATCH8 RFX7 POM121C YEATS2 NCOR1 KMT2C KMT2D ZBED4 CDK13 ARID5B PRKDC SUZ12 HCFC1 CDCA7L NUP153 | 2.04e-10 | 1294 | 182 | 28 | 30804502 |
| Pubmed | JCAD FKBP15 FLNA RANBP2 KCNH7 SLC4A7 MAGED1 ACACA TRIO KALRN PCLO UBR4 ATG2B AAK1 APC SRPRA NBEA TACC2 MAPK8IP3 PITPNM1 PLAA PLPPR4 PRRC2C PDE4DIP TNRC6A WNK2 | 3.15e-10 | 1139 | 182 | 26 | 36417873 | |
| Pubmed | TTF2 FLNA ACACA ATG2B NSD1 POGZ YEATS2 NCOR1 KMT2C KMT2D PRRC2C ARID2 TET1 PRKDC ZNF598 HCFC1 TP53BP2 HTT | 8.11e-10 | 549 | 182 | 18 | 38280479 | |
| Pubmed | FLNA RANBP2 HIVEP1 KIF26B NUP98 APC ARHGAP17 POGZ PAK6 POM121C KMT2C ARID2 TNRC6A AKAP13 PRKDC WNK2 NUP153 | 9.26e-10 | 486 | 182 | 17 | 20936779 | |
| Pubmed | MED10 HIVEP1 MAGED1 INTS12 SCAF8 UBR4 BMS1 NUP98 TWNK POGZ GPATCH8 RFX7 POM121C ZFPM2 YEATS2 NCOR1 KMT2C KMT2D ZFHX4 ATXN2 AIFM1 PRRC2C GLI3 ARID2 ARID5B TNRC6A FOXP1 HCFC1 | 1.86e-09 | 1429 | 182 | 28 | 35140242 | |
| Pubmed | RANBP2 CRYBG2 MAGED1 ZCCHC8 NUP98 EYA1 ZFPM2 KMT2C KMT2D CDK13 PRRC2C TNRC6A SUZ12 HCFC1 HYDIN CDCA7L | 4.21e-09 | 469 | 182 | 16 | 27634302 | |
| Pubmed | VIL1 HIVEP1 KALRN UBR4 PLEKHM1 KCNH6 NCOR1 KMT2C GLI3 NPC1L1 PDE4DIP WNK2 | 4.30e-09 | 233 | 182 | 12 | 37704626 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | RANBP2 HIVEP1 NUP98 POGZ RFX7 POM121C NCOR1 KMT2C KMT2D ZFHX4 ARID2 TET1 ARID5B FOXP1 | 5.74e-09 | 351 | 182 | 14 | 38297188 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | VIL1 ACACA FN1 BAZ2B KIF26B PCLO UBR4 BMS1 MUC19 SRPRA NBEA KMT2C ZBED4 ADAMTS9 AIFM1 ARID5B AKAP13 PRKDC NCR2 | 1.32e-08 | 736 | 182 | 19 | 29676528 |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.90e-08 | 123 | 182 | 9 | 26912792 | |
| Pubmed | TTF2 FLNA SP4 RANBP2 MED10 HIVEP1 INTS12 BAZ2B INPP5D POGZ YEATS2 NCOR1 KMT2C KMT2D ATXN2 CDK13 PRRC2C ARID2 EIF2S2 FOXP1 PRKDC HCFC1 NUP153 | 1.94e-08 | 1103 | 182 | 23 | 34189442 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | SCAF8 BMS1 MAMLD1 NUP98 GPATCH8 POM121C YEATS2 NCOR1 KMT2C KMT2D PIK3C2A ATXN2 PRRC2C TNRC6A NUP153 | 2.18e-08 | 457 | 182 | 15 | 32344865 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TTF2 RANBP2 SLC4A7 INTS12 VRK3 UBR4 BMS1 NUP98 TWNK POGZ NCOR1 KMT2D ZFHX4 PRRC2C NISCH EIF2S2 FOXP1 SPIDR ZNF598 HCFC1 | 2.85e-08 | 857 | 182 | 20 | 25609649 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | RANBP2 MAGED1 FN1 TRIO KALRN SCAF8 UBR4 APC NCOR1 ATXN2 PRRC2C KCNMA1 ELAVL3 MRRF HTT | 3.62e-08 | 475 | 182 | 15 | 31040226 |
| Pubmed | FKBP15 SLC4A7 MAGED1 TRIO SCAF8 APC ARHGAP17 PEX13 SRPRA GPATCH8 CLCC1 SLC4A2 YEATS2 IGF2R EIF2S2 TNRC6A AKAP13 HCFC1 | 6.90e-08 | 733 | 182 | 18 | 34672954 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ATMIN PRUNE2 ACACA UACA TRIO SCAF8 DPYSL5 AAK1 ATAT1 PLEKHM1 CLCC1 MAPK8IP3 YEATS2 KMT2C PTPRJ ATXN2 CDK13 ARID5B KCNMA1 NLRC5 FOXP1 AKAP13 SPIDR WNK2 AFF4 HTT | 7.53e-08 | 1489 | 182 | 26 | 28611215 |
| Pubmed | FLNA RANBP2 KALRN ZCCHC8 NUP98 AAK1 APC TACC2 NCOR1 CDK13 CSRP1 AKAP13 HCFC1 NUP153 MRTFA | 7.62e-08 | 503 | 182 | 15 | 16964243 | |
| Pubmed | RANBP2 SLC4A7 MAGED1 INTS12 VRK3 UACA ZCCHC8 SCAF8 BMS1 AAK1 NSD1 APC TWNK SRPRA GPATCH8 KMT2C UTP25 PIK3C2A ATXN2 CDK13 ARID2 EIF2S2 TNRC6A SUZ12 ZNF598 AFF4 | 8.36e-08 | 1497 | 182 | 26 | 31527615 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 8.42e-08 | 146 | 182 | 9 | 23892456 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | HIVEP1 MAGED1 INTS12 ZCCHC8 APC ARHGAP17 TACC2 YEATS2 NCOR1 BRCA2 PRRC2C ARID2 ARID5B TNRC6A SASS6 ZMYM6 | 9.65e-08 | 588 | 182 | 16 | 38580884 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TTF2 FKBP15 FLNA RANBP2 ACACA ZCCHC8 ATG2B NUP98 AAK1 TACC2 POM121C YEATS2 PRRC2C ARID2 PRKDC ZNF598 HCFC1 NUP153 AFF4 TP53BP2 | 1.15e-07 | 934 | 182 | 20 | 33916271 |
| Pubmed | JCAD RANBP2 TRIO CTDSPL2 BMS1 NUP98 SRPRA NBEA EYA1 CLCC1 NCOR1 KMT2D IGF2R PTPRJ ATXN2 AIFM1 PTPRZ1 TNRC6A KCNMA1 NUP153 TP53BP2 | 1.66e-07 | 1049 | 182 | 21 | 27880917 | |
| Pubmed | DMTF1 FLNA SLC4A7 FN1 NSD1 APC BBS4 APOB TACC2 GPATCH8 KMT2C IGF2R PLAA GBP4 TET1 UNC5C ARID5B CCSER2 NUP153 AFF4 MRTFA | 2.84e-07 | 1084 | 182 | 21 | 11544199 | |
| Pubmed | FLNA RANBP2 ACACA FN1 ZCCHC8 UBR4 BMS1 NUP98 NSD1 POGZ IGF2R UTP25 PRRC2C PRKDC HCFC1 NUP153 | 3.93e-07 | 653 | 182 | 16 | 22586326 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 5.00e-07 | 180 | 182 | 9 | 35198878 | |
| Pubmed | 5.62e-07 | 4 | 182 | 3 | 11839768 | ||
| Pubmed | SLC4A7 ACACA FN1 BMS1 NUP98 APC SRPRA NBEA APOB CLCC1 NCOR1 ARL3 IGF2R GLI3 UNC5C TNRC6A PRKDC | 8.05e-07 | 777 | 182 | 17 | 35844135 | |
| Pubmed | 9.47e-07 | 15 | 182 | 4 | 14697343 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | FLNA RANBP2 SLC4A7 KIF26B ATG2B NUP98 APC PRRC2C PRKDC HCFC1 | 1.11e-06 | 256 | 182 | 10 | 33397691 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | PTBP3 TTF2 SLC4A7 ZCCHC8 PCLO UBR4 ATG2B BMS1 NUP98 PEX13 TWNK SRPRA TACC2 CLCC1 PIK3C2A ATXN2 AIFM1 CDK13 ARID2 NISCH SASS6 ALDH4A1 ZNF598 MRRF | 1.13e-06 | 1496 | 182 | 24 | 32877691 |
| Pubmed | RANBP2 MAGED1 APC POM121C ATXN2 GLI3 CCSER2 TNRC6A NUP153 TP53BP2 | 1.41e-06 | 263 | 182 | 10 | 34702444 | |
| Pubmed | 1.49e-06 | 152 | 182 | 8 | 34299191 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | PTBP3 FLNA RANBP2 MAGED1 ACACA UACA AAK1 APC SRPRA POGZ PIK3C2A ATXN2 PRRC2C TNRC6A AKAP13 ZNF598 | 1.51e-06 | 724 | 182 | 16 | 36232890 |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 1.62e-06 | 38 | 182 | 5 | 12791264 | |
| Pubmed | MED10 HIVEP1 INTS12 ZCCHC8 NCOR1 KMT2D ARID5B FOXP1 HCFC1 AFF4 | 1.67e-06 | 268 | 182 | 10 | 33640491 | |
| Pubmed | SCAF8 UBR4 GPATCH8 RFX7 NCOR1 KMT2C PLAA UTP25 PRRC2C TET1 AKAP13 | 1.74e-06 | 335 | 182 | 11 | 15741177 | |
| Pubmed | ATMIN FKBP15 SCAF8 SPEG POGZ GPATCH8 YEATS2 ZBED4 PRRC2C NISCH PDE4DIP SUZ12 | 1.79e-06 | 407 | 182 | 12 | 12693553 | |
| Pubmed | PCLO AAK1 APC NBEA PEX5L MAPK8IP3 PITPNM1 PIK3C2A CSRP1 KCNMA1 HTT | 2.44e-06 | 347 | 182 | 11 | 17114649 | |
| Pubmed | Genetic and molecular control of folate-homocysteine metabolism in mutant mice. | 2.79e-06 | 6 | 182 | 3 | 12016514 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | JCAD LCA5 TTF2 RANBP2 ACACA TRIO DPYSL5 AAK1 APC CLCC1 NCOR1 IGF2R BRCA2 TNRC6A SASS6 ZNF598 TP53BP2 | 2.83e-06 | 853 | 182 | 17 | 28718761 |
| Pubmed | FKBP15 SLC4A7 ATG2B PEX13 SRPRA NBEA LYST PLEKHM1 CLCC1 SLC4A2 WDR45 IGF2R NISCH | 2.88e-06 | 504 | 182 | 13 | 34432599 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 3.01e-06 | 167 | 182 | 8 | 20362541 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | FLNA RANBP2 HIVEP1 BAZ2B NUP98 NSD1 POGZ YEATS2 NCOR1 BRCA2 ATXN2 PRRC2C ARID2 EIF2S2 PRKDC HCFC1 NUP153 AFF4 | 3.06e-06 | 954 | 182 | 18 | 36373674 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | RANBP2 ACACA NUP98 APC GPATCH8 POM121C UTP25 AIFM1 ARID2 NISCH CCSER2 NUP153 | 3.98e-06 | 440 | 182 | 12 | 34244565 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | FLNA RANBP2 MAGED1 ACACA MAMLD1 AAK1 SRPRA TACC2 YEATS2 NCOR1 BRCA2 HCFC1 | 4.36e-06 | 444 | 182 | 12 | 34795231 |
| Pubmed | JCAD TTF2 FKBP15 MAGED1 ZCCHC8 APC SRPRA PIK3C2A CCSER2 TNRC6A PRKDC TP53BP2 | 4.57e-06 | 446 | 182 | 12 | 24255178 | |
| Pubmed | 4.86e-06 | 7 | 182 | 3 | 24051001 | ||
| Pubmed | DMTF1 NUP98 AAK1 NSD1 APC TACC2 ATAT1 PEX5L GDPD5 NCOR1 ARL3 ZFHX4 SCARB2 UNC5C PDE4DIP DIXDC1 PRKDC SUZ12 | 6.34e-06 | 1006 | 182 | 18 | 15226823 | |
| Pubmed | 7.74e-06 | 8 | 182 | 3 | 32479599 | ||
| Pubmed | Imaging within single NPCs reveals NXF1's role in mRNA export on the cytoplasmic side of the pore. | 7.74e-06 | 8 | 182 | 3 | 31375530 | |
| Pubmed | PTBP3 FLNA RANBP2 MED10 ACACA VRK3 UACA NUP98 APC RFX7 NCOR1 ELL2 PIK3C2A AIFM1 EIF2S2 PRKDC ZNF598 HCFC1 AFF4 TP53BP2 | 9.52e-06 | 1247 | 182 | 20 | 27684187 | |
| Pubmed | VIL1 PTBP3 FLNA FN1 VRK3 UACA BMS1 AAK1 SRPRA APOB POGZ ANKRD36B PIK3C2A ATXN2 AIFM1 CDK13 PRRC2C TNRC6A HCFC1 MRRF AFF4 | 1.12e-05 | 1371 | 182 | 21 | 36244648 | |
| Pubmed | 1.16e-05 | 9 | 182 | 3 | 9114010 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | RANBP2 ACACA CTDSPL2 BAZ2B NUP98 KDM5D ZFPM2 YEATS2 NCOR1 PRKDC HCFC1 | 1.21e-05 | 411 | 182 | 11 | 35182466 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.21e-05 | 202 | 182 | 8 | 33005030 | |
| Pubmed | A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. | 1.35e-05 | 205 | 182 | 8 | 12040188 | |
| Pubmed | DMTF1 TTF2 FLNA HIVEP1 FN1 ZCCHC8 UBR4 TWNK NCOR1 KMT2D CDK13 PDE4DIP TP53BP2 | 1.57e-05 | 591 | 182 | 13 | 15231748 | |
| Pubmed | 1.59e-05 | 101 | 182 | 6 | 26949739 | ||
| Pubmed | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. | 2.00e-05 | 283 | 182 | 9 | 18854154 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | FLNA RANBP2 ACACA POGZ YEATS2 NCOR1 BRCA2 PRKDC HCFC1 NUP153 | 2.06e-05 | 357 | 182 | 10 | 37059091 |
| Pubmed | FLNA FN1 TRIO KALRN PCLO DPYSL5 AAK1 APC NBEA MAPK8IP3 PITPNM1 PLPPR4 PTPRZ1 PRRC2C NISCH CSRP1 PDE4DIP EIF2S2 ELAVL3 WNK2 TP53BP2 | 2.12e-05 | 1431 | 182 | 21 | 37142655 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 2.25e-05 | 220 | 182 | 8 | 35785414 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 2.35e-05 | 289 | 182 | 9 | 23752268 | |
| Pubmed | TTF2 RANBP2 ATG2B AAK1 APC SRPRA THSD1 CLCC1 IGF2R AIFM1 PRRC2C PRKDC HCFC1 NUP153 | 2.40e-05 | 708 | 182 | 14 | 39231216 | |
| Pubmed | DMTF1 SP4 HIVEP1 INTS12 POGZ KDM5D NCOR1 ZBED4 GLI3 ARID2 CSRP1 ARID5B FOXP1 ZNF598 MRTFA | 2.54e-05 | 808 | 182 | 15 | 20412781 | |
| Pubmed | BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates. | 2.72e-05 | 226 | 182 | 8 | 25900982 | |
| Pubmed | The COOH-terminal domain of huntingtin interacts with RhoGEF kalirin and modulates cell survival. | 2.72e-05 | 2 | 182 | 2 | 29789657 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 18031309 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 21813447 | ||
| Pubmed | Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease. | 2.72e-05 | 2 | 182 | 2 | 28550168 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 8140728 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 21242887 | ||
| Pubmed | Kalirin and Trio proteins serve critical roles in excitatory synaptic transmission and LTP. | 2.72e-05 | 2 | 182 | 2 | 26858404 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 1639480 | ||
| Pubmed | Translocation of bacteria from the gastrointestinal tract in immunodeficient mice. | 2.72e-05 | 2 | 182 | 2 | 8709573 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 8567125 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 8962121 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 31928221 | ||
| Pubmed | The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape. | 2.72e-05 | 2 | 182 | 2 | 34156443 | |
| Pubmed | BRCA2 suppresses cell proliferation via stabilizing MAGE-D1. | 2.72e-05 | 2 | 182 | 2 | 15930293 | |
| Pubmed | The role of FilGAP-filamin A interactions in mechanoprotection. | 2.72e-05 | 2 | 182 | 2 | 19144823 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 14970199 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 11493482 | ||
| Pubmed | Structural basis for ELL2 and AFF4 activation of HIV-1 proviral transcription. | 2.72e-05 | 2 | 182 | 2 | 28134250 | |
| Pubmed | HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2. | 2.72e-05 | 2 | 182 | 2 | 21423673 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 27280393 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 36869380 | ||
| Pubmed | The beneficial effect of blocking Kv1.3 in the psoriasiform SCID mouse model. | 2.72e-05 | 2 | 182 | 2 | 20739949 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 8418200 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 19293932 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 11924817 | ||
| Pubmed | Evaluation of three lines of immunodeficient mice for the study of spontaneous metastatic tumors. | 2.72e-05 | 2 | 182 | 2 | 10225324 | |
| Pubmed | An immunocompromised murine model of chronic Bartonella infection. | 2.72e-05 | 2 | 182 | 2 | 20395436 | |
| Interaction | YWHAH interactions | JCAD LCA5 HIVEP1 SLC4A7 INTS12 FN1 UACA TRIO KIF26B ZCCHC8 SPEG DPYSL5 AAK1 APC ARHGAP17 TWNK ZNF395 PAK6 RFX7 ATAT1 LYST ARL3 PIK3C2A PRRC2C TESK2 TET1 CCSER2 KCNMA1 AKAP13 NR3C2 WNK2 TP53BP2 HTT | 5.04e-10 | 1102 | 177 | 33 | int:YWHAH |
| Interaction | PHF21A interactions | FLNA RANBP2 HIVEP1 ACACA ZCCHC8 UBR4 ATG2B APC YEATS2 KMT2D ZFHX4 BRCA2 TET1 ARID5B TNRC6A MRTFA TP53BP2 | 1.01e-08 | 343 | 177 | 17 | int:PHF21A |
| Interaction | NUP43 interactions | FLNA RANBP2 HIVEP1 ACACA BAZ2B BMS1 NUP98 MUC19 NSD1 APC POGZ GPATCH8 POM121C YEATS2 NCOR1 KMT2D BRCA2 PRRC2C ARID2 CCSER2 HCFC1 NUP153 | 3.28e-08 | 625 | 177 | 22 | int:NUP43 |
| Interaction | YWHAQ interactions | JCAD LCA5 FLNA SLC4A7 ACACA FN1 VRK3 UACA KIF26B SPEG DPYSL5 AAK1 APC ZNF395 PAK6 RFX7 ATAT1 LYST ARL3 PIK3C2A TESK2 TET1 CCSER2 KCNMA1 AKAP13 PRKDC VWA2 TP53BP2 HTT | 1.49e-07 | 1118 | 177 | 29 | int:YWHAQ |
| Interaction | NUP35 interactions | RANBP2 SCAF8 MAMLD1 NUP98 GPATCH8 POM121C YEATS2 NCOR1 KMT2C KMT2D PIK3C2A ATXN2 PRRC2C TNRC6A PRKDC SUZ12 NUP153 | 2.17e-07 | 424 | 177 | 17 | int:NUP35 |
| Interaction | FMR1 interactions | RANBP2 ARHGAP24 MAGED1 UBR4 APC NBEA TACC2 ZFPM2 NCOR1 PLPPR4 ATXN2 PRRC2C NISCH KCNMA1 ELAVL3 DIXDC1 SUZ12 ZNF598 AFF4 | 2.72e-07 | 536 | 177 | 19 | int:FMR1 |
| Interaction | EGR2 interactions | HIVEP1 POGZ NCOR1 KMT2C KMT2D ZFHX4 ARID2 TET1 PDE4DIP FOXP1 HCFC1 | 3.44e-07 | 171 | 177 | 11 | int:EGR2 |
| Interaction | RCOR1 interactions | FLNA RANBP2 HIVEP1 ACACA ZCCHC8 UBR4 ATG2B APC YEATS2 NCOR1 KMT2D ZFHX4 BRCA2 TET1 ARID5B SUZ12 MRTFA TP53BP2 | 3.84e-07 | 494 | 177 | 18 | int:RCOR1 |
| Interaction | SYNE3 interactions | JCAD RANBP2 NUP98 APC SRPRA POM121C CLCC1 YEATS2 NCOR1 IGF2R BRCA2 PIK3C2A GLI3 CCSER2 TNRC6A ZNF598 TP53BP2 | 4.14e-07 | 444 | 177 | 17 | int:SYNE3 |
| Interaction | TOP3B interactions | ATMIN FLNA CRYBG2 ACACA TRIO KALRN SPEG UBR4 NSD1 ARHGAP17 TWNK APOB ZNF395 POM121C LYST PLEKHM1 MAPK8IP3 GDPD5 NCOR1 KMT2C KMT2D IGF2R ZBED4 ATXN2 CDK13 NISCH NLRC5 AKAP13 PRKDC ZNF598 HCFC1 WNK2 HTT | 5.15e-07 | 1470 | 177 | 33 | int:TOP3B |
| Interaction | HDAC1 interactions | FLNA RANBP2 HIVEP1 ACACA FN1 ZCCHC8 UBR4 ATG2B NUP98 APC SRPRA ZNF395 ZFPM2 YEATS2 NCOR1 KMT2D ZFHX4 BRCA2 AIFM1 GLI3 TET1 ARID5B TNRC6A SUZ12 HCFC1 MRTFA TP53BP2 | 1.41e-06 | 1108 | 177 | 27 | int:HDAC1 |
| Interaction | YWHAZ interactions | JCAD LCA5 HIVEP1 SLC4A7 FN1 UACA KIF26B SPEG AAK1 APC SRPRA TACC2 ZNF395 PAK6 ATAT1 LYST NCOR1 ARL3 PIK3C2A NISCH TESK2 CCSER2 KCNMA1 AKAP13 CEP126 ZNF598 VWA2 WNK2 TP53BP2 HTT | 1.42e-06 | 1319 | 177 | 30 | int:YWHAZ |
| Interaction | YWHAG interactions | JCAD LCA5 FLNA HIVEP1 SLC4A7 FN1 UACA KIF26B SPEG DPYSL5 AAK1 APC ARHGAP17 ZNF395 PAK6 RFX7 ATAT1 LYST ARL3 PIK3C2A PRRC2C TESK2 TET1 CCSER2 KCNMA1 AKAP13 PRKDC TP53BP2 HTT | 1.42e-06 | 1248 | 177 | 29 | int:YWHAG |
| Interaction | KDM1A interactions | FLNA RANBP2 HIVEP1 ACACA ZCCHC8 UBR4 ATG2B APC POGZ YEATS2 NCOR1 KMT2D ZFHX4 BRCA2 ANKEF1 TET1 PDE4DIP ARID5B TNRC6A FOXP1 ZNF598 MRTFA TP53BP2 HTT | 2.67e-06 | 941 | 177 | 24 | int:KDM1A |
| Interaction | MAPRE1 interactions | LCA5 FLNA RANBP2 FN1 TRIO NUP98 APC ARHGAP17 TACC2 PRRC2C PDE4DIP EIF2S2 CCSER2 SUZ12 ZNF598 POM121B NUP153 | 3.06e-06 | 514 | 177 | 17 | int:MAPRE1 |
| Interaction | LHX1 interactions | 3.53e-06 | 103 | 177 | 8 | int:LHX1 | |
| Interaction | HNF1B interactions | 7.21e-06 | 190 | 177 | 10 | int:HNF1B | |
| Interaction | SOX7 interactions | 7.82e-06 | 82 | 177 | 7 | int:SOX7 | |
| Interaction | YWHAB interactions | LCA5 HIVEP1 SLC4A7 FN1 UACA KIF26B ZCCHC8 SPEG AAK1 APC ZNF395 PAK6 RFX7 ATAT1 LYST ARL3 PIK3C2A TESK2 CCSER2 KCNMA1 AKAP13 VWA2 TP53BP2 HTT | 9.45e-06 | 1014 | 177 | 24 | int:YWHAB |
| Interaction | FOXL1 interactions | RANBP2 HIVEP1 NUP98 NCOR1 KMT2C KMT2D ZFHX4 ARID5B FOXP1 SPIDR | 9.47e-06 | 196 | 177 | 10 | int:FOXL1 |
| Interaction | PAX2 interactions | 9.93e-06 | 85 | 177 | 7 | int:PAX2 | |
| Interaction | PFN1 interactions | TTF2 RANBP2 ARHGAP24 FN1 TRIO PCLO AAK1 APC ARHGAP17 NBEA EYA1 PIK3C2A AKAP13 AFF4 MRTFA HTT | 1.14e-05 | 509 | 177 | 16 | int:PFN1 |
| Interaction | ASF1A interactions | HIVEP1 NSD1 POGZ YEATS2 NCOR1 KMT2D BRCA2 ARID2 ARID5B HCFC1 ZMYM6 | 1.32e-05 | 249 | 177 | 11 | int:ASF1A |
| Interaction | YWHAE interactions | JCAD LCA5 FLNA HIVEP1 SLC4A7 FN1 KIF26B AAK1 APC TACC2 ZNF395 PAK6 ATAT1 LYST ARL3 PIK3C2A CDK13 NISCH TESK2 TET1 CCSER2 KCNMA1 AKAP13 ZNF598 WNK2 TP53BP2 HTT | 1.43e-05 | 1256 | 177 | 27 | int:YWHAE |
| Interaction | GJA1 interactions | FLNA SLC4A7 UACA TRIO KALRN APC SRPRA NBEA APOB THSD1 CLCC1 SLC4A2 RGS14 IGF2R NISCH UNC5C HTT | 1.59e-05 | 583 | 177 | 17 | int:GJA1 |
| Interaction | SP7 interactions | HIVEP1 INTS12 SCAF8 POGZ GPATCH8 NCOR1 KMT2C KMT2D ZFHX4 ARID2 ARID5B FOXP1 | 1.64e-05 | 304 | 177 | 12 | int:SP7 |
| Interaction | AR interactions | FLNA MED10 HIVEP1 MAGED1 INTS12 FN1 ZCCHC8 NSD1 PAK6 NCOR1 KMT2C KMT2D PLAA GLI3 ARID2 NISCH ARID5B FOXP1 NR3C2 PRKDC SUZ12 HCFC1 AFF4 | 2.05e-05 | 992 | 177 | 23 | int:AR |
| Interaction | AMOT interactions | JCAD FKBP15 FLNA ARHGAP24 UBR4 APC ARHGAP17 WDR45 PIK3C2A CCSER2 TNRC6A TP53BP2 | 2.13e-05 | 312 | 177 | 12 | int:AMOT |
| Interaction | AP2B1 interactions | FKBP15 FLNA ARHGAP24 FN1 AAK1 APC PEX5L IGF2R UTP25 PIK3C2A TNRC6A AFF4 HTT | 2.70e-05 | 373 | 177 | 13 | int:AP2B1 |
| Interaction | ATG16L1 interactions | PTBP3 FKBP15 FLNA RANBP2 MED10 MAGED1 ACACA ZCCHC8 SPEG INPP5D ATG2B APC SRPRA GPATCH8 IGF2R PIK3C2A PRRC2C CCSER2 TNRC6A SASS6 AKAP13 DIXDC1 PARP9 HCFC1 MRRF | 2.99e-05 | 1161 | 177 | 25 | int:ATG16L1 |
| Interaction | SRF interactions | 3.20e-05 | 139 | 177 | 8 | int:SRF | |
| Interaction | HNF4A interactions | MED10 HIVEP1 MUC19 POGZ YEATS2 NCOR1 KMT2C KMT2D ARID2 FOXP1 SUZ12 | 3.30e-05 | 275 | 177 | 11 | int:HNF4A |
| Interaction | LHX2 interactions | 3.56e-05 | 183 | 177 | 9 | int:LHX2 | |
| Interaction | EN1 interactions | 5.32e-05 | 110 | 177 | 7 | int:EN1 | |
| Interaction | CLTA interactions | FKBP15 FLNA FN1 AAK1 TWNK NBEA WDR45 IGF2R PIK3C2A TNRC6A WNK2 HTT | 6.66e-05 | 351 | 177 | 12 | int:CLTA |
| Interaction | EGLN3 interactions | JCAD RANBP2 MAGED1 ACACA SCAF8 UBR4 ATG2B APC GPATCH8 ZFPM2 NCOR1 IGF2R PLAA BRCA2 PIK3C2A ATXN2 AIFM1 GLI3 NISCH ARID5B CCSER2 AKAP13 NR3C2 PRKDC HCFC1 NUP153 | 6.69e-05 | 1296 | 177 | 26 | int:EGLN3 |
| Interaction | GATA2 interactions | 6.83e-05 | 199 | 177 | 9 | int:GATA2 | |
| Interaction | TBXT interactions | 7.47e-05 | 116 | 177 | 7 | int:TBXT | |
| Interaction | FEV interactions | 7.96e-05 | 203 | 177 | 9 | int:FEV | |
| Interaction | ACTR3 interactions | FKBP15 FLNA FN1 APC ARHGAP17 RGS14 ARL3 SCARB2 TNRC6A KCNMA1 HTT | 8.40e-05 | 305 | 177 | 11 | int:ACTR3 |
| Interaction | NANOG interactions | RANBP2 MAGED1 ZCCHC8 POGZ GPATCH8 YEATS2 NCOR1 KMT2C BRCA2 TET1 ARID5B SASS6 SUZ12 HCFC1 | 9.33e-05 | 481 | 177 | 14 | int:NANOG |
| Interaction | FBXO42 interactions | HIVEP1 MAGED1 INTS12 ZCCHC8 APC ARHGAP17 TACC2 YEATS2 ARID2 TNRC6A | 1.01e-04 | 259 | 177 | 10 | int:FBXO42 |
| Interaction | GSC interactions | 1.18e-04 | 87 | 177 | 6 | int:GSC | |
| Interaction | RNF123 interactions | VIL1 ACACA FN1 BAZ2B KIF26B PCLO UBR4 BMS1 MUC19 SRPRA NBEA KMT2C ZBED4 ADAMTS9 AIFM1 ARID5B AKAP13 PRKDC NCR2 | 1.21e-04 | 824 | 177 | 19 | int:RNF123 |
| Interaction | FLT3 interactions | TTF2 INPP5D UBR4 PCDHA12 PCDHA8 SRPRA APOB BRCA2 EIF2S2 PRKDC SUZ12 | 1.21e-04 | 318 | 177 | 11 | int:FLT3 |
| Interaction | ASH2L interactions | ZCCHC8 YEATS2 KMT2C KMT2D BRCA2 TNRC6A SUZ12 HCFC1 ZMYM6 HTT | 1.22e-04 | 265 | 177 | 10 | int:ASH2L |
| Interaction | TLE3 interactions | FLNA HIVEP1 MAGED1 BAZ2B SCAF8 GPATCH8 NCOR1 KMT2D BRCA2 ARID2 ARID5B TNRC6A | 1.28e-04 | 376 | 177 | 12 | int:TLE3 |
| Interaction | TLX1 interactions | 1.61e-04 | 175 | 177 | 8 | int:TLX1 | |
| Interaction | TEAD1 interactions | 1.68e-04 | 176 | 177 | 8 | int:TEAD1 | |
| Interaction | CNOT9 interactions | 2.11e-04 | 231 | 177 | 9 | int:CNOT9 | |
| Interaction | LHX3 interactions | 2.36e-04 | 185 | 177 | 8 | int:LHX3 | |
| Interaction | BMI1 interactions | PTBP3 RANBP2 ACACA KIF26B ZCCHC8 SCAF8 NSD1 TWNK GPATCH8 ATXN2 AIFM1 PRRC2C CSRP1 NLRC5 PRKDC CEP126 | 2.40e-04 | 659 | 177 | 16 | int:BMI1 |
| Interaction | TOMM20 interactions | 2.80e-04 | 240 | 177 | 9 | int:TOMM20 | |
| Interaction | FAM120C interactions | 2.93e-04 | 191 | 177 | 8 | int:FAM120C | |
| Interaction | SOX2 interactions | PTBP3 FLNA RANBP2 HIVEP1 MAGED1 FN1 VRK3 BAZ2B ZCCHC8 UBR4 NUP98 NSD1 TWNK POGZ EYA1 NCOR1 KMT2C KMT2D ZFHX4 AIFM1 GLI3 ARID2 EIF2S2 ARID5B TNRC6A FOXP1 | 2.94e-04 | 1422 | 177 | 26 | int:SOX2 |
| Interaction | EMILIN1 interactions | 2.98e-04 | 103 | 177 | 6 | int:EMILIN1 | |
| Interaction | SIRT7 interactions | FLNA RANBP2 MAGED1 ACACA FN1 ZCCHC8 UBR4 BMS1 NUP98 NSD1 POGZ IGF2R UTP25 PRRC2C PRKDC HCFC1 NUP153 | 3.10e-04 | 744 | 177 | 17 | int:SIRT7 |
| Interaction | PPIA interactions | TTF2 FN1 TRIO BMS1 LYST SLC4A2 YEATS2 IGF2R AIFM1 ARID2 CSRP1 KCNMA1 SASS6 ZNF598 HCFC1 NUP153 MRTFA TP53BP2 KLB | 3.13e-04 | 888 | 177 | 19 | int:PPIA |
| Interaction | ELF5 interactions | 3.25e-04 | 147 | 177 | 7 | int:ELF5 | |
| Interaction | GCM1 interactions | 3.29e-04 | 68 | 177 | 5 | int:GCM1 | |
| Interaction | KPNB1 interactions | LCA5 RANBP2 ARHGAP24 FN1 CTDSPL2 UBR4 NUP98 POM121C LYST RGS14 SUZ12 ZNF598 NUP153 HTT | 3.31e-04 | 544 | 177 | 14 | int:KPNB1 |
| Interaction | HMGA1 interactions | FN1 VRK3 INPP5D PCLO NSD1 POGZ BRCA2 EIF2S2 PRKDC SUZ12 HCFC1 HTT | 3.44e-04 | 419 | 177 | 12 | int:HMGA1 |
| Interaction | WWTR1 interactions | TTF2 ATG2B POGZ YEATS2 NCOR1 KMT2D PRRC2C ARID2 ZNF598 HCFC1 TP53BP2 HTT | 3.67e-04 | 422 | 177 | 12 | int:WWTR1 |
| Interaction | CDK9 interactions | VIL1 FLNA ACACA BMS1 NUP98 APC ARHGAP17 ELL2 BRCA2 AIFM1 CDK13 PRRC2C CSRP1 PRKDC ZMYM6 AFF4 | 3.68e-04 | 685 | 177 | 16 | int:CDK9 |
| Interaction | NAA40 interactions | TTF2 FKBP15 FLNA RANBP2 ACACA ZCCHC8 ATG2B NUP98 AAK1 TACC2 POM121C YEATS2 PRRC2C ARID2 PRKDC ZNF598 HCFC1 NUP153 AFF4 TP53BP2 | 3.88e-04 | 978 | 177 | 20 | int:NAA40 |
| Interaction | RNF43 interactions | RANBP2 MAGED1 NUP98 APC POM121C ATXN2 GLI3 CCSER2 TNRC6A ENPEP NUP153 TP53BP2 | 4.08e-04 | 427 | 177 | 12 | int:RNF43 |
| Interaction | DVL2 interactions | VIL1 LCA5 FKBP15 ACACA AAK1 APC GPATCH8 HMCN1 AIFM1 PDE4DIP ARID5B SASS6 ZNF598 HTT | 4.20e-04 | 557 | 177 | 14 | int:DVL2 |
| Interaction | HDAC11 interactions | 4.30e-04 | 154 | 177 | 7 | int:HDAC11 | |
| Interaction | PPP1CA interactions | FLNA FN1 VRK3 AAK1 APC NCOR1 RGS14 GLI3 SCARB2 NR3C2 PRKDC CEP126 HCFC1 NUP153 TP53BP2 HTT | 4.38e-04 | 696 | 177 | 16 | int:PPP1CA |
| Interaction | PAX8 interactions | 4.46e-04 | 111 | 177 | 6 | int:PAX8 | |
| GeneFamily | PHD finger proteins | 4.29e-05 | 90 | 128 | 6 | 88 | |
| GeneFamily | AT-rich interaction domain containing | 1.48e-04 | 15 | 128 | 3 | 418 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.06e-04 | 181 | 128 | 7 | 694 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 7.11e-04 | 25 | 128 | 3 | 775 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.01e-03 | 161 | 128 | 6 | 593 | |
| GeneFamily | Nucleoporins | 1.48e-03 | 32 | 128 | 3 | 1051 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.73e-03 | 9 | 128 | 2 | 1230 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 1.73e-03 | 9 | 128 | 2 | 1280 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.77e-03 | 34 | 128 | 3 | 487 | |
| GeneFamily | ATAC complex | 3.69e-03 | 13 | 128 | 2 | 1058 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RANBP2 HIVEP1 SLC4A7 TRIO BAZ2B SCAF8 MAMLD1 NUP98 APC GPATCH8 ELL2 IGF2R BRCA2 PIK3C2A ATXN2 CDK13 PRRC2C ARID5B CCSER2 AKAP13 SUZ12 SPIDR NUP153 MRTFA TP53BP2 | 7.83e-10 | 856 | 177 | 25 | M4500 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | DMTF1 PTBP3 FLNA RANBP2 SLC4A7 SCAF8 INPP5D UBR4 NUP98 AAK1 NSD1 EVI2B SRPRA GPATCH8 RFX7 LYST NCOR1 RGS14 KMT2C LRRN3 KMT2D PTPRJ CDK13 ARID2 PDE4DIP CCSER2 NLRC5 AKAP13 PARP9 SUZ12 NUP153 | 2.13e-08 | 1492 | 177 | 31 | M40023 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | PTBP3 CDKN2D FKBP15 SP4 ARHGAP24 SPEG PCLO MUC19 APC NBEA RFX7 PEX5L LYST ZFPM2 ANKRD36B LRRN3 ZFHX4 PLPPR4 PDE4DIP TNRC6A KCNMA1 ELAVL3 CEP126 HYDIN | 4.68e-07 | 1106 | 177 | 24 | M39071 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | HIVEP1 SLC4A7 TRIO BAZ2B SCAF8 MAMLD1 NUP98 ATXN2 CDK13 PRRC2C ARID5B CCSER2 SUZ12 NUP153 TP53BP2 | 7.05e-07 | 466 | 177 | 15 | M13522 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | PRUNE2 PTBP3 RANBP2 SLC4A7 SPEG PCLO APC SRPRA NBEA ZNF395 LYST KMT2C PTPRJ PIK3C2A ATXN2 NISCH PDE4DIP CCSER2 KCNMA1 AFF4 | 6.73e-06 | 946 | 177 | 20 | M39169 |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 1.20e-05 | 157 | 177 | 8 | M7733 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | ATMIN JCAD FKBP15 TRIO KALRN BAZ2B SPEG ATAT1 MFRP MAPK8IP3 NCOR1 LRRN3 PTPRZ1 PRRC2C NISCH SCARB2 SASS6 ELAVL3 FOXP1 DIXDC1 HTT | 1.87e-05 | 1102 | 177 | 21 | M2369 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | MAGED1 BAZ2B KDM5D RFX7 NCOR1 KMT2C PTPRJ PRRC2C CSRP1 ARID5B TNRC6A MYOCD ENPEP | 1.87e-05 | 467 | 177 | 13 | M1347 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | ATMIN JCAD FKBP15 TRIO KALRN BAZ2B SPEG ATAT1 MFRP MAPK8IP3 NCOR1 LRRN3 PTPRZ1 PRRC2C NISCH SCARB2 SASS6 ELAVL3 FOXP1 DIXDC1 HTT | 2.50e-05 | 1124 | 177 | 21 | MM1070 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | MAGED1 BAZ2B KDM5D RFX7 NCOR1 KMT2C PTPRJ PRRC2C CSRP1 ARID5B TNRC6A MYOCD ENPEP | 2.72e-05 | 484 | 177 | 13 | MM999 |
| Coexpression | GSE17721_LPS_VS_CPG_0.5H_BMDC_UP | 6.31e-05 | 198 | 177 | 8 | M3982 | |
| Coexpression | GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_UP | 6.53e-05 | 199 | 177 | 8 | M5620 | |
| Coexpression | GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_DN | 6.77e-05 | 200 | 177 | 8 | M7205 | |
| Coexpression | BUSSLINGER_DUODENAL_MATURE_ENTEROCYTES | 7.06e-05 | 259 | 177 | 9 | M40029 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | TTF2 RANBP2 INTS12 ANGPT2 FN1 CTDSPL2 EMILIN2 TWNK CLCC1 YEATS2 ZSCAN32 GBP4 UTP25 BRCA2 PIK3C2A PRRC2C ARID2 TET1 EIF2S2 KCNMA1 SASS6 PRKDC SUZ12 | 7.93e-05 | 1407 | 177 | 23 | M14427 |
| Coexpression | LEE_AGING_NEOCORTEX_DN | 9.80e-05 | 68 | 177 | 5 | M1497 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN | 1.00e-04 | 36 | 177 | 4 | M13327 | |
| Coexpression | GSE11386_NAIVE_VS_MEMORY_BCELL_DN | 1.03e-04 | 158 | 177 | 7 | M372 | |
| Coexpression | HOOI_ST7_TARGETS_DN | 1.33e-04 | 115 | 177 | 6 | M14801 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 1.40e-04 | 166 | 177 | 7 | M8129 | |
| Coexpression | FIRESTEIN_PROLIFERATION | 1.40e-04 | 166 | 177 | 7 | M5354 | |
| Coexpression | GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP | 1.40e-04 | 166 | 177 | 7 | M7722 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | TTF2 RANBP2 SLC4A7 UACA APC RFX7 UTP25 BRCA2 PIK3C2A PRRC2C GLI3 TET1 EIF2S2 PRKDC CEP126 | 7.84e-06 | 469 | 174 | 15 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | LCA5 HIVEP1 TRIO SCAF8 BBS4 ARHGAP17 NBEA ZFPM2 MAPK8IP3 NCOR1 HMCN1 ZFHX4 GLI3 CLN5 CSRP1 EIF2S2 FOXP1 MYOCD DIXDC1 ZMYM6 | 8.07e-06 | 791 | 174 | 20 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | SLC4A7 CTDSPL2 KIF26B EMILIN2 PEX13 RFX7 YEATS2 NCOR1 PLAA HMCN1 ZFHX4 TESK2 FOXP1 DIXDC1 VWA2 | 9.82e-06 | 478 | 174 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5 |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#2 | 1.15e-05 | 170 | 174 | 9 | ratio_DE_vs_SC_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | TTF2 RANBP2 SLC4A7 PCLO ARHGAP17 RFX7 PLAA ZBED4 BRCA2 PRRC2C GLI3 EIF2S2 PRKDC SUZ12 CEP126 | 3.41e-05 | 532 | 174 | 15 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.43e-05 | 195 | 174 | 9 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_500 | CTDSPL2 KIF26B EMILIN2 PEX13 NBEA RFX7 NCOR1 ELL2 PLAA ZFHX4 | 3.85e-05 | 247 | 174 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 4.34e-05 | 201 | 174 | 9 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | TTF2 UACA SCAF8 PCLO DPYSL5 TWNK PEX5L PLAA ZBED4 UTP25 PIK3C2A ADAMTS9 PTPRZ1 PRRC2C GLI3 TET1 ELAVL3 PRKDC HCFC1 CDCA7L NUP153 | 6.74e-05 | 994 | 174 | 21 | Facebase_RNAseq_e8.5_Floor Plate_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | SP4 TRIO BAZ2B NBEA KDM5D MFRP KMT2C LRRN3 IGF2R PLAA ATXN2 ADAMTS9 PRRC2C NISCH TET1 ARID5B TNRC6A HTT | 1.07e-04 | 801 | 174 | 18 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#1 | JCAD ANGPT2 FN1 KIF26B MAMLD1 LYST ZFPM2 GBP4 ADAMTS9 CSRP1 ARID5B | 1.39e-04 | 346 | 174 | 11 | ratio_DE_vs_SC_1000_K1 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | FLNA ARHGAP24 FN1 UACA KIF26B EYA1 KDM5D ZFPM2 LRRN3 IGF2R HMCN1 ADAMTS9 GLI3 TET1 UNC5C MYOCD ENPEP | 2.30e-04 | 777 | 174 | 17 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_500 | JCAD ARHGAP24 OVCH2 ANGPT2 FN1 KIF26B ZFPM2 GBP4 ZFHX4 ADAMTS9 ARID5B NPAP1 MYOCD | 2.31e-04 | 495 | 174 | 13 | PCBC_ratio_DE_vs_SC_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.62e-04 | 312 | 174 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#1 | JCAD ARHGAP24 OVCH2 ANGPT2 FN1 ZFPM2 GBP4 ADAMTS9 ARID5B NPAP1 MYOCD | 2.72e-04 | 374 | 174 | 11 | ratio_DE_vs_SC_500_K1 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | FLNA MAGED1 FN1 KIF26B MAMLD1 EYA1 KDM5D ZFPM2 LRRN3 HMCN1 ADAMTS9 GLI3 SCARB2 UNC5C SASS6 MYOCD ENPEP | 2.91e-04 | 793 | 174 | 17 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 2.96e-04 | 259 | 174 | 9 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.96e-04 | 259 | 174 | 9 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SLC4A7 MAGED1 PCLO NSD1 NBEA KDM5D NCOR1 KMT2C PRRC2C NISCH AFF4 | 4.76e-10 | 195 | 180 | 11 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | ACACA TRIO BAZ2B NBEA RFX7 KMT2C PTPRJ TNRC6A KCNMA1 NR3C2 SPIDR | 5.91e-10 | 199 | 180 | 11 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PLB1 MUC19 HMCN1 ZFHX4 PTPRZ1 UNC5C KCNMA1 MYOCD TDRD6 HYDIN | 1.11e-09 | 160 | 180 | 10 | c381ec6be8cf887861cc18f831a20db42f953fe1 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PLB1 MUC19 HMCN1 ZFHX4 PTPRZ1 UNC5C KCNMA1 MYOCD TDRD6 HYDIN | 1.11e-09 | 160 | 180 | 10 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | PRUNE2 FLNA SPEG ELL2 ADAMTS9 CSRP1 UNC5C KCNMA1 MYOCD ENPEP | 3.29e-09 | 179 | 180 | 10 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 4.06e-09 | 183 | 180 | 10 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | PRUNE2 FLNA FN1 KALRN ADAMTS9 CSRP1 UNC5C KCNMA1 MYOCD ENPEP | 4.06e-09 | 183 | 180 | 10 | cae2ee08f985a6f005b4b8e959e465350315156a |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | FLNA ANGPT2 KALRN SPEG ARHGAP17 CSRP1 UNC5C KCNMA1 MYOCD WNK2 | 6.45e-09 | 192 | 180 | 10 | bfab13793e54de2550ee171397f7ece0625cdb4a |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | FLNA ANGPT2 KALRN SPEG ARHGAP17 CSRP1 UNC5C KCNMA1 MYOCD WNK2 | 6.45e-09 | 192 | 180 | 10 | b54b0d5b88139905521c8d5d58332e89c08d589c |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 5.33e-08 | 180 | 180 | 9 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 9.26e-08 | 192 | 180 | 9 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.68e-08 | 193 | 180 | 9 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-07 | 194 | 180 | 9 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-07 | 194 | 180 | 9 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-07 | 194 | 180 | 9 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-07 | 195 | 180 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-07 | 196 | 180 | 9 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-07 | 196 | 180 | 9 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.15e-07 | 197 | 180 | 9 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.26e-07 | 199 | 180 | 9 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.31e-07 | 200 | 180 | 9 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 1.31e-07 | 200 | 180 | 9 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.31e-07 | 200 | 180 | 9 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.31e-07 | 200 | 180 | 9 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.31e-07 | 200 | 180 | 9 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-07 | 158 | 180 | 8 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-07 | 158 | 180 | 8 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-07 | 158 | 180 | 8 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.98e-07 | 160 | 180 | 8 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 3.13e-07 | 161 | 180 | 8 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 4.95e-07 | 171 | 180 | 8 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.90e-07 | 175 | 180 | 8 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.90e-07 | 175 | 180 | 8 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.00e-07 | 179 | 180 | 8 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.93e-07 | 182 | 180 | 8 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.62e-07 | 184 | 180 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.62e-07 | 184 | 180 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.62e-07 | 184 | 180 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.97e-07 | 185 | 180 | 8 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-06 | 188 | 180 | 8 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.10e-06 | 190 | 180 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.19e-06 | 192 | 180 | 8 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-06 | 192 | 180 | 8 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-06 | 194 | 180 | 8 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-06 | 198 | 180 | 8 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-06 | 198 | 180 | 8 | d1827e3707b929e3a3562989a0c11537d344e164 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.55e-06 | 199 | 180 | 8 | 8ff0fdcbe9661b013913731ec8b53d84836ca865 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.55e-06 | 199 | 180 | 8 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.61e-06 | 200 | 180 | 8 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-06 | 200 | 180 | 8 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.61e-06 | 200 | 180 | 8 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.61e-06 | 200 | 180 | 8 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.61e-06 | 200 | 180 | 8 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.16e-06 | 154 | 180 | 7 | 16fdafb5c64d2db321554f87129a962d113f1668 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 4.41e-06 | 162 | 180 | 7 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | C_02|World / shred on cell type and cluster | 4.98e-06 | 165 | 180 | 7 | a456c2c9ffe8dc91e17cac84ba87b88e016f8e6d | |
| ToppCell | ileum|World / shred on tissue and cell subclass | 6.06e-06 | 170 | 180 | 7 | 9f1211bd4287620e19a59f21e6ecdca3e42e0260 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.79e-06 | 173 | 180 | 7 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.06e-06 | 174 | 180 | 7 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_Tfh|metastatic_Brain / Location, Cell class and cell subclass | 7.33e-06 | 175 | 180 | 7 | b732c6a423c28856211002107d8c611dcfb6f265 | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.33e-06 | 175 | 180 | 7 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.60e-06 | 176 | 180 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 7.60e-06 | 176 | 180 | 7 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 7.89e-06 | 177 | 180 | 7 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.18e-06 | 178 | 180 | 7 | d3a75a8082e70543b84c35d53fe77625300d19fa | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.18e-06 | 178 | 180 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.18e-06 | 178 | 180 | 7 | b2cda1df801b1a1a41e3dd2808baef37765cd804 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.13e-06 | 181 | 180 | 7 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.13e-06 | 181 | 180 | 7 | ab0f300d14b62cef57f1b0bdae143b8dfe8e6975 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 9.80e-06 | 183 | 180 | 7 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.80e-06 | 183 | 180 | 7 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 184 | 180 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | ILEUM-inflamed-(7)_Lymphatics|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.05e-05 | 185 | 180 | 7 | d711dd2e91cfee723dae1ccb2b910b8cf3becc3b | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.05e-05 | 185 | 180 | 7 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-05 | 186 | 180 | 7 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.09e-05 | 186 | 180 | 7 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.09e-05 | 186 | 180 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 186 | 180 | 7 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.09e-05 | 186 | 180 | 7 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.13e-05 | 187 | 180 | 7 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 187 | 180 | 7 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-05 | 188 | 180 | 7 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-05 | 188 | 180 | 7 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-05 | 188 | 180 | 7 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-05 | 188 | 180 | 7 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 189 | 180 | 7 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 189 | 180 | 7 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 189 | 180 | 7 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 189 | 180 | 7 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 189 | 180 | 7 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.21e-05 | 189 | 180 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.25e-05 | 190 | 180 | 7 | 9ce301841ce9486701fa28eb2a9929e35d476878 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 190 | 180 | 7 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 191 | 180 | 7 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 1.29e-05 | 191 | 180 | 7 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 191 | 180 | 7 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 191 | 180 | 7 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | IPF-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 1.34e-05 | 192 | 180 | 7 | 9b06c7336624ef21f8e5393725b56038a8028e57 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.38e-05 | 193 | 180 | 7 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.38e-05 | 193 | 180 | 7 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| Drug | geldanamycin | PTBP3 SP4 FN1 CTDSPL2 SRPRA RFX7 ELL2 ZFHX4 PLPPR4 CDK13 PRRC2C PDE4DIP MYOCD AFF4 HTT | 2.12e-07 | 371 | 176 | 15 | ctd:C001277 |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | TRIO SCAF8 TACC2 YEATS2 ZFHX4 ATXN2 CDK13 GLI3 CCSER2 AKAP13 | 9.10e-07 | 171 | 176 | 10 | 7535_DN |
| Drug | 2,4,4'-trichlorobiphenyl | PRUNE2 PTBP3 LCA5 TTF2 FLNA HIVEP1 FN1 KALRN BAZ2B KIF26B NEUROD4 PCDHA8 PEX5L PITPNM1 GDPD5 LRRN3 GBP4 ZFHX4 PTPRJ BRCA2 CSRP1 PDE4DIP KCNMA1 FOXP1 NR3C2 TDRD6 HCFC1 CDCA7L RUFY4 | 1.30e-06 | 1411 | 176 | 29 | ctd:C081766 |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | PRUNE2 PTBP3 LCA5 TTF2 FLNA HIVEP1 FN1 KALRN BAZ2B KIF26B NEUROD4 PCDHA8 PEX5L PITPNM1 GDPD5 LRRN3 GBP4 ZFHX4 PTPRJ BRCA2 CSRP1 PDE4DIP KCNMA1 FOXP1 NR3C2 TDRD6 HCFC1 CDCA7L RUFY4 | 1.98e-06 | 1441 | 176 | 29 | ctd:C009828 |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | TRIO MAMLD1 NUP98 ZSCAN32 IGF2R PRRC2C TESK2 SCARB2 CCSER2 ALDH4A1 | 2.15e-06 | 188 | 176 | 10 | 4845_DN |
| Drug | Nifenazone [2139-47-1]; Up 200; 13uM; MCF7; HT_HG-U133A | JCAD ARHGAP24 NEUROD4 MAPK8IP3 KCNH6 RGS14 KCNMA1 SPIDR HCFC1 ALOX15B | 3.42e-06 | 198 | 176 | 10 | 2285_UP |
| Drug | Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; HL60; HT_HG-U133A | 3.74e-06 | 200 | 176 | 10 | 2434_UP | |
| Drug | C768-0445; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.64e-05 | 188 | 176 | 9 | 865_UP | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.01e-05 | 193 | 176 | 9 | 1022_DN | |
| Drug | Aceclofenac [89796-99-6]; Up 200; 11.2uM; PC3; HT_HG-U133A | 2.28e-05 | 196 | 176 | 9 | 7269_UP | |
| Drug | Sulfadiazine [68-35-9]; Up 200; 16uM; PC3; HT_HG-U133A | 2.28e-05 | 196 | 176 | 9 | 1810_UP | |
| Drug | R(+)-verapamil hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 2.37e-05 | 197 | 176 | 9 | 164_DN | |
| Drug | Glipizide [29094-61-9]; Down 200; 9uM; MCF7; HT_HG-U133A | 2.37e-05 | 197 | 176 | 9 | 1508_DN | |
| Drug | CAS 81-11-8 | 2.38e-05 | 110 | 176 | 7 | CID000006668 | |
| Drug | Midecamycin [35457-80-8]; Down 200; 5uM; PC3; HG-U133A | 2.47e-05 | 198 | 176 | 9 | 1943_DN | |
| Drug | Miconazole | 2.47e-05 | 8 | 176 | 3 | DB01110 | |
| Drug | Dacarbazine [4342-03-4]; Down 200; 22uM; MCF7; HT_HG-U133A | 2.57e-05 | 199 | 176 | 9 | 2754_DN | |
| Drug | CP-320650-01 [172079-28-6]; Up 200; 1uM; PC3; HT_HG-U133A | 2.57e-05 | 199 | 176 | 9 | 4560_UP | |
| Drug | Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; PC3; HT_HG-U133A | 2.57e-05 | 199 | 176 | 9 | 7254_DN | |
| Drug | Cotinine (-) [486-56-6]; Up 200; 22.6uM; HL60; HG-U133A | 2.67e-05 | 200 | 176 | 9 | 2011_UP | |
| Drug | 1-AR | 3.84e-05 | 25 | 176 | 4 | CID000445014 | |
| Drug | HQ-cysteine | 5.94e-05 | 2 | 176 | 2 | CID000161996 | |
| Drug | Melphalan | 6.04e-05 | 276 | 176 | 10 | ctd:D008558 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 7.90e-05 | 179 | 176 | 8 | 4184_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 8.87e-05 | 182 | 176 | 8 | 6316_UP | |
| Drug | XE991 | 1.19e-04 | 33 | 176 | 4 | CID000656732 | |
| Drug | Piperacetazine [3819-00-9]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.24e-04 | 191 | 176 | 8 | 3574_UP | |
| Drug | Carbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 1.29e-04 | 192 | 176 | 8 | 4110_DN | |
| Drug | Glycocholic acid [475-31-0]; Down 200; 8.6uM; PC3; HT_HG-U133A | 1.33e-04 | 193 | 176 | 8 | 6716_DN | |
| Drug | Ergocryptine-alpha [511-09-1]; Up 200; 7uM; MCF7; HT_HG-U133A | 1.33e-04 | 193 | 176 | 8 | 3434_UP | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 1.38e-04 | 194 | 176 | 8 | 4281_DN | |
| Drug | Doxazosin mesylate [77883-43-3]; Down 200; 7.4uM; PC3; HT_HG-U133A | 1.38e-04 | 194 | 176 | 8 | 6642_DN | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; HL60; HT_HG-U133A | 1.38e-04 | 194 | 176 | 8 | 2735_DN | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; PC3; HT_HG-U133A | 1.38e-04 | 194 | 176 | 8 | 6705_DN | |
| Drug | Hydrocortisone base [50-23-7]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.38e-04 | 194 | 176 | 8 | 3284_UP | |
| Drug | Famotidine [76824-35-6]; Up 200; 11.8uM; PC3; HG-U133A | 1.43e-04 | 195 | 176 | 8 | 1946_UP | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; PC3; HG-U133A | 1.43e-04 | 195 | 176 | 8 | 1944_UP | |
| Drug | Pentoxifylline [6493-05-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 1.43e-04 | 195 | 176 | 8 | 2290_UP | |
| Drug | Naphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; PC3; HG-U133A | 1.43e-04 | 195 | 176 | 8 | 1886_DN | |
| Drug | Alfadolone acetate [23930-37-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.48e-04 | 196 | 176 | 8 | 6506_DN | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.48e-04 | 196 | 176 | 8 | 5765_DN | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; PC3; HT_HG-U133A | 1.48e-04 | 196 | 176 | 8 | 2099_DN | |
| Drug | Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 1.48e-04 | 196 | 176 | 8 | 4718_DN | |
| Drug | Gliclazide [21187-98-4]; Up 200; 12.4uM; HL60; HG-U133A | 1.48e-04 | 196 | 176 | 8 | 1720_UP | |
| Drug | Sulpiride [15676-16-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 1467_UP | |
| Drug | 0393-0188; Up 200; 10uM; PC3; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 7510_UP | |
| Drug | Ambroxol hydrochloride [23828-92-4]; Up 200; 9.6uM; PC3; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 6719_UP | |
| Drug | Cefazolin sodium salt [27164-46-1]; Up 200; 8.4uM; PC3; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 3686_UP | |
| Drug | Mafenide hydrochloride [138-37-4]; Down 200; 18uM; PC3; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 2124_DN | |
| Drug | Guanethidine sulfate [60-02-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 3171_DN | |
| Drug | Mimosine [500-44-7]; Up 200; 20.2uM; PC3; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 6703_UP | |
| Drug | L(-)-vesamicol hydrochloride [112709-59-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 6497_UP | |
| Drug | Thalidomide [50-35-1]; Down 200; 15.4uM; PC3; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 2095_DN | |
| Drug | Reserpine [50-55-5]; Down 200; 6.6uM; HL60; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 3003_DN | |
| Drug | Fluorocurarine chloride [22273-09-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 6083_DN | |
| Drug | Ethionamide [536-33-4]; Up 200; 24uM; HL60; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 2495_UP | |
| Drug | Pizotifen malate [5189-11-7]; Up 200; 9.4uM; HL60; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 3134_UP | |
| Drug | Alprenolol hydrochloride [13707-88-5]; Down 200; 14uM; HL60; HG-U133A | 1.59e-04 | 198 | 176 | 8 | 1571_DN | |
| Drug | Tranexamic acid [1197-18-8]; Up 200; 25.4uM; MCF7; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 6238_UP | |
| Drug | Chlorpropamide [94-20-2]; Up 200; 14.4uM; HL60; HG-U133A | 1.59e-04 | 198 | 176 | 8 | 1594_UP | |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; PC3; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 6287_DN | |
| Drug | THIP Hydrochloride; Down 200; 22.6uM; PC3; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 7266_DN | |
| Drug | pioglitazone HCl; Down 200; 10uM; MCF7; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 7506_DN | |
| Drug | Dimenhydrinate [523-87-5]; Up 200; 8.6uM; PC3; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 6352_UP | |
| Drug | Tetramisole hydrochloride [16595-80-5]; Up 200; 16.6uM; HL60; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 2489_UP | |
| Drug | exemestane; Down 200; 0.01uM; MCF7; HG-U133A | 1.64e-04 | 199 | 176 | 8 | 165_DN | |
| Drug | Furosemide [54-31-9]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.64e-04 | 199 | 176 | 8 | 6841_UP | |
| Drug | Suxibuzone [27470-51-5]; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.64e-04 | 199 | 176 | 8 | 5806_UP | |
| Drug | Delsoline [509-18-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.64e-04 | 199 | 176 | 8 | 7212_DN | |
| Drug | thioridazine hydrochloride; Down 200; 1uM; MCF7; HG-U133A | 1.64e-04 | 199 | 176 | 8 | 422_DN | |
| Drug | Sulfabenzamide [127-71-9]; Down 200; 14.4uM; PC3; HT_HG-U133A | 1.64e-04 | 199 | 176 | 8 | 6634_DN | |
| Drug | Tolazoline hydrochloride [59-97-2]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 1.64e-04 | 199 | 176 | 8 | 1500_UP | |
| Drug | Cyclizine hydrochloride [303-25-3]; Up 200; 13.2uM; PC3; HT_HG-U133A | 1.64e-04 | 199 | 176 | 8 | 5100_UP | |
| Drug | Trichlorfon [52-68-6]; Up 200; 15.6uM; PC3; HT_HG-U133A | 1.64e-04 | 199 | 176 | 8 | 7287_UP | |
| Drug | Acetazolamide [59-66-5]; Down 200; 18uM; MCF7; HT_HG-U133A | 1.64e-04 | 199 | 176 | 8 | 7461_DN | |
| Drug | Lincomycin hydrochloride [859-18-7]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.64e-04 | 199 | 176 | 8 | 5992_UP | |
| Drug | Gentamicine sulfate [1405-41-0]; Down 200; 2.6uM; PC3; HT_HG-U133A | 1.70e-04 | 200 | 176 | 8 | 5883_DN | |
| Drug | Arg-Phe-Asp-Ser | 1.77e-04 | 3 | 176 | 2 | CID005236782 | |
| Drug | 4-allyloxyaniline | 1.77e-04 | 3 | 176 | 2 | CID006504204 | |
| Disease | lymphocyte count | JCAD TTF2 HIVEP1 SLC4A7 ACACA FN1 KALRN NSD1 SIGLEC5 PEX13 ZNF395 RFX7 LYST ZFPM2 NCOR1 PTPRJ ATXN2 CDK13 ARID5B NLRC5 FOXP1 NR3C2 VWA2 MRTFA HTT | 2.17e-06 | 1464 | 176 | 25 | EFO_0004587 |
| Disease | intraocular pressure measurement | JCAD TTF2 ANGPT2 KALRN PCLO MFRP MAPK8IP3 PTPRJ ATXN2 FAM186A ARID5B FOXP1 AKAP13 | 1.27e-05 | 509 | 176 | 13 | EFO_0004695 |
| Disease | Intellectual Disability | TRIO ZCCHC8 NSD1 APC NBEA POGZ MAPK8IP3 KMT2C ALDH4A1 SUZ12 ZMYM6 HTT | 1.69e-05 | 447 | 176 | 12 | C3714756 |
| Disease | neutrophil percentage of leukocytes | HIVEP1 KALRN BAZ2B SIGLEC5 ATXN2 CDK13 ARID5B NLRC5 FOXP1 AKAP13 NR3C2 PRKDC MRTFA HTT | 1.93e-05 | 610 | 176 | 14 | EFO_0007990 |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 3.54e-05 | 2 | 176 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | apolipoprotein B measurement | DCHS2 SP4 FN1 DPYSL5 SRPRA APOB CLCC1 IGF2R BRCA2 ATXN2 NISCH NPC1L1 HYDIN HTT | 4.77e-05 | 663 | 176 | 14 | EFO_0004615 |
| Disease | anemia (implicated_via_orthology) | 9.00e-05 | 15 | 176 | 3 | DOID:2355 (implicated_via_orthology) | |
| Disease | pulse pressure measurement | JCAD ARHGAP24 SLC4A7 FN1 PCDHA12 PCDHA8 NBEA POGZ GPATCH8 ZFPM2 ARL3 ZFHX4 PIK3C2A TET1 TNRC6A FOXP1 AKAP13 ENPEP HCFC1 HYDIN KLB | 9.08e-05 | 1392 | 176 | 21 | EFO_0005763 |
| Disease | osteopetrosis (is_implicated_in) | 1.06e-04 | 3 | 176 | 2 | DOID:13533 (is_implicated_in) | |
| Disease | aspartate aminotransferase measurement | SP4 PLB1 SLC4A7 KALRN MUC19 NSD1 EVI2B EYA1 POM121C PLEKHM1 PTPRJ ATXN2 ADAMTS9 NLRC5 AKAP13 WNK2 | 1.10e-04 | 904 | 176 | 16 | EFO_0004736 |
| Disease | chronic obstructive pulmonary disease, interleukin-8 measurement | 2.11e-04 | 4 | 176 | 2 | EFO_0000341, EFO_0004811 | |
| Disease | mean arterial pressure | ARHGAP24 SLC4A7 POM121C YEATS2 ARL3 UTP25 PTPRJ ATXN2 TNRC6A KCNMA1 ENPEP | 2.17e-04 | 499 | 176 | 11 | EFO_0006340 |
| Disease | neuroimaging measurement | DCHS2 KIF26B DPYSL5 APC TACC2 PAK6 POM121C MAPK8IP3 NCOR1 ATXN2 PRRC2C GLI3 TNRC6A FOXP1 ABCG2 WNK2 HTT | 2.39e-04 | 1069 | 176 | 17 | EFO_0004346 |
| Disease | Neurodevelopmental Disorders | 2.43e-04 | 93 | 176 | 5 | C1535926 | |
| Disease | myocardial infarction | 2.69e-04 | 350 | 176 | 9 | EFO_0000612 | |
| Disease | Colorectal Carcinoma | ACACA FN1 KALRN APC APOB PAK6 PEX5L KMT2C GLI3 NPAP1 NR3C2 ABCG2 VWA2 | 3.21e-04 | 702 | 176 | 13 | C0009402 |
| Disease | Prostatic Neoplasms | APC PAK6 SLC4A2 NCOR1 KMT2C KMT2D IGF2R BRCA2 ARID2 CSRP1 AKAP13 PRKDC | 3.48e-04 | 616 | 176 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | APC PAK6 SLC4A2 NCOR1 KMT2C KMT2D IGF2R BRCA2 ARID2 CSRP1 AKAP13 PRKDC | 3.48e-04 | 616 | 176 | 12 | C0376358 |
| Disease | Weaver syndrome | 3.50e-04 | 5 | 176 | 2 | C0265210 | |
| Disease | Malignant Cystosarcoma Phyllodes | 3.50e-04 | 5 | 176 | 2 | C0600066 | |
| Disease | Phyllodes Tumor | 3.50e-04 | 5 | 176 | 2 | C0010701 | |
| Disease | monocyte count | JCAD TTF2 CRYBG2 HIVEP1 FN1 KALRN BAZ2B INPP5D SIGLEC5 LYST PLEKHM1 ZFPM2 ATXN2 NLRC5 AKAP13 PRKDC SPIDR VWA2 MRTFA | 3.59e-04 | 1320 | 176 | 19 | EFO_0005091 |
| Disease | Bell's palsy | 3.72e-04 | 102 | 176 | 5 | EFO_0007167 | |
| Disease | cortical surface area measurement | DCHS2 SP4 BAZ2B KIF26B DPYSL5 APC EYA1 PLEKHM1 NCOR1 ARL3 ATXN2 ADAMTS9 PRRC2C GLI3 UNC5C TNRC6A FOXP1 NR3C2 WNK2 | 4.52e-04 | 1345 | 176 | 19 | EFO_0010736 |
| Disease | galectin-7 measurement | 5.22e-04 | 6 | 176 | 2 | EFO_0022034 | |
| Disease | neutrophil count | PRUNE2 JCAD HIVEP1 INPP5D NSD1 PCDHA12 PCDHA8 POGZ ZFPM2 PTPRJ ATXN2 FAM186A TNRC6A NLRC5 FOXP1 AKAP13 PRKDC HYDIN HTT | 6.28e-04 | 1382 | 176 | 19 | EFO_0004833 |
| Disease | lymphocyte measurement | 6.97e-04 | 117 | 176 | 5 | EFO_0803546 | |
| Disease | hereditary lymphedema (is_implicated_in) | 7.28e-04 | 7 | 176 | 2 | DOID:0050580 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | FLNA FN1 KALRN UBR4 NUP98 TACC2 NCOR1 KMT2D BRCA2 NISCH ANKEF1 EIF2S2 NLRC5 ABCG2 ENPEP TP53BP2 | 7.39e-04 | 1074 | 176 | 16 | C0006142 |
| Disease | Abnormality of refraction | JCAD PCLO MAMLD1 PCDHA12 PCDHA8 NBEA ADAMTS9 GLI3 ARID2 KCNMA1 FOXP1 AKAP13 | 7.58e-04 | 673 | 176 | 12 | HP_0000539 |
| Disease | amino acid measurement | PTBP3 MED10 TACC2 PTPRJ NISCH KCNMA1 NR3C2 ABCG2 PRKDC WNK2 MRTFA HTT | 8.08e-04 | 678 | 176 | 12 | EFO_0005134 |
| Disease | coronary artery disease | JCAD KCNH7 FN1 INPP5D AAK1 APOB ZFPM2 MAPK8IP3 GDPD5 IGF2R PTPRJ ATXN2 UNC5C AKAP13 ABCG2 WNK2 MRTFA | 8.34e-04 | 1194 | 176 | 17 | EFO_0001645 |
| Disease | heart conduction disease (implicated_via_orthology) | 9.11e-04 | 32 | 176 | 3 | DOID:10273 (implicated_via_orthology) | |
| Disease | creatinine measurement | VIL1 KIF26B SCAF8 SPEG DPYSL5 NSD1 EYA1 RGS14 IGF2R PTPRJ PRRC2C ARID5B KCNMA1 ABCG2 MRTFA | 9.61e-04 | 995 | 176 | 15 | EFO_0004518 |
| Disease | LDL cholesterol change measurement, response to simvastatin, response to fenofibrate | 9.67e-04 | 8 | 176 | 2 | EFO_0007804, GO_1901557, GO_1903491 | |
| Disease | tumor necrosis factor receptor II measurement | 9.67e-04 | 8 | 176 | 2 | EFO_0008384 | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 9.73e-04 | 126 | 176 | 5 | EFO_0004611, EFO_0010351 | |
| Disease | waist-hip ratio | PRUNE2 JCAD FN1 EMILIN2 NSD1 BBS4 EYA1 RFX7 YEATS2 ATXN2 ADAMTS9 GLI3 NISCH ARID5B TNRC6A DIXDC1 HTT | 1.11e-03 | 1226 | 176 | 17 | EFO_0004343 |
| Disease | hematocrit | JCAD HIVEP1 ACACA KALRN MAMLD1 AAK1 APOB ZFPM2 SLC4A2 RGS14 PTPRJ ATXN2 ARID2 FOXP1 HYDIN | 1.13e-03 | 1011 | 176 | 15 | EFO_0004348 |
| Disease | HEPATOCELLULAR CARCINOMA | 1.24e-03 | 9 | 176 | 2 | 114550 | |
| Disease | Hepatocellular carcinoma | 1.24e-03 | 9 | 176 | 2 | cv:C2239176 | |
| Disease | Adenoma, Microcystic | 1.29e-03 | 36 | 176 | 3 | C0205648 | |
| Disease | Adenoma, Monomorphic | 1.29e-03 | 36 | 176 | 3 | C0205649 | |
| Disease | Adenoma, Basal Cell | 1.29e-03 | 36 | 176 | 3 | C0205646 | |
| Disease | Follicular adenoma | 1.29e-03 | 36 | 176 | 3 | C0205647 | |
| Disease | Papillary adenoma | 1.29e-03 | 36 | 176 | 3 | C0205650 | |
| Disease | Adenoma, Trabecular | 1.29e-03 | 36 | 176 | 3 | C0205651 | |
| Disease | Adenoma | 1.29e-03 | 36 | 176 | 3 | C0001430 | |
| Disease | multiple myeloma (is_marker_for) | 1.29e-03 | 36 | 176 | 3 | DOID:9538 (is_marker_for) | |
| Disease | Glioblastoma | 1.30e-03 | 79 | 176 | 4 | C0017636 | |
| Disease | venous thromboembolism, factor VII measurement | 1.51e-03 | 38 | 176 | 3 | EFO_0004286, EFO_0004619 | |
| Disease | medulloblastoma (is_implicated_in) | 1.54e-03 | 10 | 176 | 2 | DOID:0050902 (is_implicated_in) | |
| Disease | triacylglycerol 54:1 measurement | 1.54e-03 | 10 | 176 | 2 | EFO_0010419 | |
| Disease | membranoproliferative glomerulonephritis (biomarker_via_orthology) | 1.54e-03 | 10 | 176 | 2 | DOID:2920 (biomarker_via_orthology) | |
| Disease | long QT syndrome (implicated_via_orthology) | 1.54e-03 | 10 | 176 | 2 | DOID:2843 (implicated_via_orthology) | |
| Disease | Giant Cell Glioblastoma | 1.63e-03 | 84 | 176 | 4 | C0334588 | |
| Disease | Microphthalmos | 1.88e-03 | 11 | 176 | 2 | C0026010 | |
| Disease | guanosine diphosphate measurement | 1.88e-03 | 11 | 176 | 2 | EFO_0010494 | |
| Disease | venous thromboembolism, response to antineoplastic agent | 1.88e-03 | 41 | 176 | 3 | EFO_0004286, GO_0097327 | |
| Disease | platelet component distribution width | PRUNE2 JCAD SLC4A7 KALRN MAMLD1 SIGLEC5 ZFPM2 ATXN2 PRRC2C TESK2 AKAP13 NR3C2 | 2.00e-03 | 755 | 176 | 12 | EFO_0007984 |
| Disease | colorectal cancer, endometrial neoplasm | 2.02e-03 | 42 | 176 | 3 | EFO_0004230, MONDO_0005575 | |
| Disease | venous thromboembolism, von Willebrand factor measurement | 2.02e-03 | 42 | 176 | 3 | EFO_0004286, EFO_0004629 | |
| Disease | reaction time measurement | KCNH7 MUC19 APC TACC2 KMT2D UTP25 ATXN2 PTPRZ1 TET1 ARID5B FOXP1 | 2.08e-03 | 658 | 176 | 11 | EFO_0008393 |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 2.18e-03 | 91 | 176 | 4 | EFO_0004611, EFO_0005271 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.23e-03 | 152 | 176 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Huntington Disease, Late Onset | 2.24e-03 | 12 | 176 | 2 | C0393574 | |
| Disease | Akinetic-Rigid Variant of Huntington Disease | 2.24e-03 | 12 | 176 | 2 | C0751207 | |
| Disease | Juvenile Huntington Disease | 2.24e-03 | 12 | 176 | 2 | C0751208 | |
| Disease | lymphocyte percentage of leukocytes | CDKN2D HIVEP1 RFX7 ATXN2 CDK13 ARID5B NLRC5 FOXP1 NR3C2 PRKDC MRTFA | 2.25e-03 | 665 | 176 | 11 | EFO_0007993 |
| Disease | coffee consumption measurement, tea consumption measurement | 2.31e-03 | 44 | 176 | 3 | EFO_0006781, EFO_0010091 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.33e-03 | 224 | 176 | 6 | EFO_0004574, EFO_0008317 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 2.38e-03 | 225 | 176 | 6 | EFO_0008317, EFO_0010351 | |
| Disease | cognitive function measurement | SP4 KCNH7 HIVEP1 KALRN DPYSL5 NBEA PLEKHM1 ZFPM2 KMT2D PLAA PRRC2C GLI3 TNRC6A FOXP1 HYDIN CDCA7L WNK2 MRTFA | 2.39e-03 | 1434 | 176 | 18 | EFO_0008354 |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 2.46e-03 | 45 | 176 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | Benign tumor of pancreas | 2.64e-03 | 13 | 176 | 2 | C0347284 | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 2.64e-03 | 13 | 176 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | Glaucoma, Primary Open Angle | 2.64e-03 | 13 | 176 | 2 | C0339573 | |
| Disease | colon carcinoma (is_marker_for) | 2.64e-03 | 13 | 176 | 2 | DOID:1520 (is_marker_for) | |
| Disease | gallbladder cancer (is_implicated_in) | 2.64e-03 | 13 | 176 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 2.75e-03 | 97 | 176 | 4 | EFO_0007878, EFO_0009458 | |
| Disease | cystatin C measurement | 2.96e-03 | 402 | 176 | 8 | EFO_0004617 | |
| Disease | epilepsy (implicated_via_orthology) | 3.01e-03 | 163 | 176 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | nephroblastoma (is_implicated_in) | 3.07e-03 | 14 | 176 | 2 | DOID:2154 (is_implicated_in) | |
| Disease | C-X-C motif chemokine 11 measurement | 3.07e-03 | 14 | 176 | 2 | EFO_0008057 | |
| Disease | Adenoid Cystic Carcinoma | 3.07e-03 | 100 | 176 | 4 | C0010606 | |
| Disease | response to olanzapine | 3.53e-03 | 15 | 176 | 2 | GO_0097333 | |
| Disease | response to statin, LDL cholesterol change measurement | 3.53e-03 | 15 | 176 | 2 | EFO_0007804, GO_0036273 | |
| Disease | Peroxisome biogenesis disorders | 3.53e-03 | 15 | 176 | 2 | C1832200 | |
| Disease | nose morphology measurement | 3.72e-03 | 329 | 176 | 7 | EFO_0007843 | |
| Disease | non-high density lipoprotein cholesterol measurement | HIVEP1 FN1 NSD1 APOB EYA1 ATAT1 IGF2R BRCA2 ATXN2 NPC1L1 HYDIN | 3.82e-03 | 713 | 176 | 11 | EFO_0005689 |
| Disease | Huntington's disease (is_marker_for) | 3.93e-03 | 53 | 176 | 3 | DOID:12858 (is_marker_for) | |
| Disease | blood phosphate measurement | 3.98e-03 | 174 | 176 | 5 | EFO_0010972 | |
| Disease | Rolandic epilepsy | 4.02e-03 | 16 | 176 | 2 | Orphanet_1945 | |
| Disease | remnant cholesterol measurement | 4.05e-03 | 108 | 176 | 4 | EFO_0010815 | |
| Disease | aortic measurement | 4.07e-03 | 251 | 176 | 6 | EFO_0020865 | |
| Disease | plasminogen activator inhibitor 1 measurement | 4.14e-03 | 54 | 176 | 3 | EFO_0004792 | |
| Disease | diet measurement | TTF2 TRIO KIF26B APOB GPATCH8 PLEKHM1 ZFPM2 ARID2 TNRC6A FOXP1 NR3C2 ABCG2 PRKDC KLB | 4.26e-03 | 1049 | 176 | 14 | EFO_0008111 |
| Disease | Mammary Carcinoma, Human | 4.43e-03 | 525 | 176 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 4.43e-03 | 525 | 176 | 9 | C1257931 | |
| Disease | Glioblastoma Multiforme | 4.46e-03 | 111 | 176 | 4 | C1621958 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EATPRASKGAQAGTQ | 181 | P04920 | |
| STSKPASFQQPLGSN | 451 | Q96RK4 | |
| IAKLNNSSPNSSGGV | 496 | O00472 | |
| NKNGTSGSDSPGQAV | 156 | Q05D32 | |
| LRGSSSQKAGETNTP | 56 | A0A1B0GTR3 | |
| LRGSSSQKAGETNTP | 56 | P0DPH9 | |
| GSATNKFQNPQTEGV | 196 | Q2M2I8 | |
| NPKSATEQSGTGIRS | 516 | O95831 | |
| EKGVNGSINGSNTSS | 166 | Q9UIF8 | |
| HNSQSNGFLLPTAGK | 486 | Q155Q3 | |
| NTNGFPATASNDLKA | 16 | Q9UNQ0 | |
| ILSSTSQTNKGPEGQ | 2746 | Q12802 | |
| GKISSISQPGNDFST | 411 | O15123 | |
| KQDEPGQAGSQKSST | 1701 | Q68CP9 | |
| GQAGSQKSSTKQPTV | 1706 | Q68CP9 | |
| TPTQGFNIKSVQSQG | 46 | P36405 | |
| PSSGTVQELNFRSNK | 521 | Q13085 | |
| INDKSTGSIVGQQPF | 506 | P30038 | |
| LEKGANPNAINSSTG | 171 | Q9NU02 | |
| PLLGTNGATDDSKTN | 26 | Q14576 | |
| EGQQSGTVSPQKQSA | 316 | Q8N2N9 | |
| LKQGASPNVQDTSGT | 61 | P55273 | |
| SQVSSGQKLGPQNFI | 621 | Q14692 | |
| ENKSGSGVPNSNTNS | 421 | Q9Y222 | |
| GVLPSSQLKSQGSSN | 1061 | Q14004 | |
| SVGQDQTLSPGSKQE | 561 | Q13625 | |
| ISFSGPKQPSQNDSA | 1766 | Q96BY7 | |
| PFPTKESQQSNFGTG | 346 | Q9UHB7 | |
| QTIGPRNTFNFGSKN | 1091 | P49792 | |
| GQQLPALAAKSGQSF | 2586 | Q96L73 | |
| LGKSELGQETTPSFN | 296 | Q8IXQ6 | |
| SLPSGNNNGKVLTTE | 76 | Q96CB8 | |
| QESSKVLNTNGTSGF | 21 | Q9UKR3 | |
| SNLTKTQGSQGESPN | 341 | Q9UPP5 | |
| TSQAAGTPKGQQESG | 121 | Q9BY79 | |
| SSQAGGELKSSTPAQ | 1931 | P51610 | |
| FGNKPTLTLGTNTNT | 391 | P52948 | |
| QGSNGTDGASQKTPS | 101 | Q12913 | |
| ESGQAPKASSRQSAG | 671 | Q9Y5H6 | |
| KAQSLGPAEFQGASQ | 176 | Q9NQU5 | |
| GTSAKNSELLSPGAN | 1471 | P10071 | |
| SPNFSSVKQGHGNLS | 3526 | Q8NEZ4 | |
| VSGAIPNNSTQGSSK | 51 | P08235 | |
| SAFKVQNATTKGPNG | 76 | Q9Y5V3 | |
| INNGSSQADGTLKPV | 131 | Q12791 | |
| RTGSSPTQGIVNKAF | 361 | Q9UPT6 | |
| FPGSQAQSKAQVLQS | 16 | O95944 | |
| GNVSPNTNSEKIFSI | 631 | Q9NS40 | |
| RNSNKGLPQSTISFD | 246 | Q99700 | |
| LSFSTKSLPQAVGQG | 1756 | Q2KJY2 | |
| SQQQSPTEKAGASGQ | 371 | Q9P266 | |
| LSSIAKGVNGSSQAP | 1101 | Q8WW38 | |
| SGFPVSNSKQNLSPE | 441 | Q9BY66 | |
| SVGFGNVSPNTNSEK | 476 | Q9H252 | |
| TTNPNASKFAQKIGG | 101 | P21291 | |
| DKGGPFTAVQITNTT | 256 | Q9UKJ3 | |
| AQQSTKPVSQTGSGK | 551 | Q9Y6V0 | |
| GKTLEPGNNNTEATS | 6721 | Q7Z5P9 | |
| GILNQSSGSSPDSNK | 766 | O00443 | |
| SQPELSGGKSALNSE | 216 | Q8IYB4 | |
| FSGQSISPAKVTAGQ | 66 | P34910 | |
| IKTEGGLSQSQSPGQ | 146 | Q99502 | |
| QGTAATGNQATPKTA | 51 | Q5T1M5 | |
| GTETKSNGSAIQNGS | 6 | Q9H334 | |
| GGKSESVANLQAQPS | 1736 | O60229 | |
| DISFSTPKGEGQNSG | 526 | Q86VQ0 | |
| KKINNGTNPETTTSG | 76 | A8MZA4 | |
| KRNGFPLGSTVQSET | 76 | Q96PP9 | |
| PGFQQTSGSKEAVAS | 406 | Q8WTR4 | |
| KEGITLNSSNPSGNA | 601 | Q07075 | |
| GFTQSDLNGKTNPEV | 86 | Q96GN5 | |
| LSPFAESSQLKGQTG | 81 | Q96RR1 | |
| VSDFQPSSQAGLNQK | 26 | Q9BTT4 | |
| GKGDVPNTSLNSTSQ | 491 | P23471 | |
| KFSNEQGLPGSNASL | 551 | Q6IE36 | |
| NKKDDGISFSNQTGP | 151 | P20042 | |
| LSPVKNSFSGQTGVS | 346 | Q8IZQ8 | |
| TSQLGAEGKSQPESQ | 101 | Q86WI3 | |
| LKDGSPVSSFSNGLQ | 2046 | Q96RW7 | |
| ESNPGTKFAIDQNTG | 2386 | Q6V1P9 | |
| APKQSFLFGTQNTSP | 676 | A8CG34 | |
| SPAPKQSFLFGTQNT | 281 | A6NF01 | |
| SIKGAGAISNFLPNN | 1341 | Q9UHC9 | |
| KYNPQSGSVLEQGSA | 256 | O15488 | |
| SNAEGLEKTQTTPNG | 441 | Q8N264 | |
| EELNQKSFSGPSNLG | 136 | Q9H7U1 | |
| EGPLTSFGLSNKINS | 2951 | P04114 | |
| QDGPSISFNAQTTLK | 351 | Q9P2N4 | |
| STGVQVNFGKSPSNP | 381 | O43313 | |
| SQFDGLSSNPSKSQG | 1326 | P42858 | |
| NITVSFEGNPSGSKT | 5076 | Q4G0P3 | |
| PSIGQVDSSKQFEGT | 1171 | P51587 | |
| PGPSSSSFQNVGNKV | 386 | A2CJ06 | |
| NLPQSFQVDTSKAGV | 1466 | P21333 | |
| GNQESPKATGVFTTL | 1071 | P02751 | |
| NNFGQSVLLSSSEPK | 986 | Q9P2H0 | |
| AASSPTQKEVVQGSG | 556 | Q8N1P7 | |
| SNGVSSQKYPGILNS | 1406 | Q99698 | |
| AASKQGSATKQQGPT | 311 | Q13495 | |
| GVNSSSPNTGNQDSK | 341 | Q5SQI0 | |
| NGFSLKESTPDVQGQ | 506 | Q86Z14 | |
| GDTETGQSPGVFNTK | 241 | Q9BXX0 | |
| TSGPNLSDNKSGQKV | 471 | A6NE01 | |
| QKATPQDSQEGTFGS | 326 | Q9UPN6 | |
| TKPNASLGDVQSGAT | 566 | Q6UVJ0 | |
| PSKVGTVALFSNGTQ | 536 | Q16820 | |
| KTISASTQVQGGDFN | 411 | Q9BPU6 | |
| ENGQAPKTSSRASVG | 671 | Q9UN75 | |
| EQTSGSFSQLSGKPQ | 226 | Q6NXP2 | |
| SGIQTNVINGKPQFS | 296 | O15296 | |
| NGTITNPINGKSFSL | 2136 | P11717 | |
| LEFSKAQVNSVPTNG | 311 | Q9Y4G2 | |
| NSQFLSGPQKSSSPF | 261 | Q68CQ4 | |
| KSGNSSTPGQFQVIQ | 141 | Q02446 | |
| QSAPGNLDNSKSGEI | 381 | Q9Y6M7 | |
| SGKISSGNSFPPQQA | 471 | Q3ZLR7 | |
| DSVGNKNSQVFPLTT | 1241 | O60522 | |
| SKETGLQGTQLASFP | 2581 | Q8WUY3 | |
| SQLFYGGEPQSQKST | 156 | P0C7N4 | |
| IKVDGSFPQDNNGSL | 511 | Q9H3W5 | |
| SSGTNFQGLPSKIDT | 161 | Q68EM7 | |
| NNVRKSDQGSPGIFT | 271 | Q7RTZ1 | |
| GQSNQTTNPKLAPSF | 276 | Q7Z3K3 | |
| FVNGATSKNLPAVQT | 1856 | Q8NFP9 | |
| KGNPESSNKQENSGS | 111 | A0A1B0GUY1 | |
| NLGTSGQQEKPGSSS | 221 | A0A1B0GUY1 | |
| SISQGTPIKFDNNSG | 1381 | O75376 | |
| GVPNGTGQKNSKDST | 1611 | Q9Y520 | |
| IFLGNSTPSTQGQGK | 286 | Q6ZNE9 | |
| DNFNKTLNIRTSPGS | 101 | Q96E11 | |
| FVSKNGPGTVDSQGQ | 716 | Q92835 | |
| PLEGNSSQGSFKVNS | 371 | O15389 | |
| FLSPASQKSSNLEGG | 11 | A0A0B4J1U4 | |
| QFGDNGTTISAVSNK | 101 | Q14108 | |
| QQQSFTNPTLTKGAT | 351 | Q92968 | |
| NQPGTVVASASQKGT | 201 | Q9Y484 | |
| VGTGKETSPNAFLNQ | 456 | Q6P1J6 | |
| GQQKSDSSFILGNPA | 906 | Q9NZP6 | |
| VTNKNADSPGLSSGS | 671 | Q969V6 | |
| QGQNSIPSSSLKGFS | 561 | Q8N1H7 | |
| SGKISSGNSFPPQQA | 471 | P0C7V6 | |
| AQLSQAGPSKSDRGS | 531 | Q8NFU7 | |
| PQESKGISQFQVLGS | 931 | Q14865 | |
| ARQTSQIGGSSKAPS | 2286 | P25054 | |
| NETSVFGPTGNKTLG | 271 | O75503 | |
| SQSAKPVSGQDTSGN | 491 | Q96S66 | |
| SGPGDANSKQADVQT | 441 | O00562 | |
| QGVLQSSPKNTEGST | 586 | Q7Z2D5 | |
| QGTGANNTKAFEVPA | 521 | P09327 | |
| SNKDSVSVAGGTQPL | 1131 | Q86UP3 | |
| NFQAPGVKSGNKRSS | 406 | Q6NZY4 | |
| GQKSALQGNSPDSEA | 21 | Q9NX65 | |
| TFKGSQSSHQRPGEQ | 161 | Q9NX65 | |
| QKSSSFSQGEAEPRG | 2126 | Q15772 | |
| ANRAGQGPFSNSSEK | 2751 | Q15772 | |
| GGEAPQVTASKAQAS | 151 | A0A1B0GUW6 | |
| FQNTSGNPSLTAEEK | 56 | Q14159 | |
| QTKPGNFPSLAVSSN | 221 | Q15022 | |
| SGSESFQSNAQKIIP | 511 | Q9NS62 | |
| KVSGTEGPFGTSNIQ | 191 | Q9Y2I1 | |
| VGSSGANQQTSGKVL | 381 | Q9Y263 | |
| GSQVQTAFGLDTKPT | 576 | Q5GFL6 | |
| STSGLQQVAFQPGQK | 66 | Q9H8N7 | |
| EGAAQNSTKPSATKG | 301 | P08240 | |
| PGNLQGEDSQAFSSK | 591 | O95359 | |
| QGSKRGLNSSFETSP | 46 | Q8IV63 | |
| QTPSALLGQKSNTDG | 466 | Q2KHR2 | |
| SNTDGALQKPSNEGV | 476 | Q2KHR2 | |
| TKSNSTGQINFSPGD | 1221 | Q2KHR2 | |
| QTKSAAQPIGGSLNS | 546 | O43566 | |
| QTLTSTGNFKFGDQG | 916 | P49790 | |
| GQEDQGLTKDFSNSP | 441 | O95758 | |
| SGKDPNSKDNSVGIQ | 2261 | P78527 | |
| NGLSQLTYTSGNPTK | 1336 | Q9BZF9 | |
| LSAQATGSGQPTRKA | 521 | Q86UK7 | |
| KGTNSSAVPLSQGQV | 361 | O95789 | |
| DSTGLSGKAVQTQQP | 2036 | Q9Y3S1 | |
| FSTSGIGLQTQGKQD | 556 | Q96S53 | |
| TKPGGFTIEISNNNS | 2331 | Q5T4S7 | |
| SSALNGGFQPVNIKA | 416 | O95185 | |
| NESGTSPKSSEGLQF | 1046 | P15822 | |
| SPKSSEGLQFQNALG | 1051 | P15822 | |
| VSGTQKVSFSGQPQN | 431 | Q8NDV7 | |
| GKAASTSRPLETQGN | 106 | A6NL46 | |
| SFPKKNSGSGNADLQ | 291 | O75962 | |
| QVTAAGPQKSGSQGS | 721 | Q9ULM3 | |
| GAAFSQGKSLTLPQT | 216 | Q2M3W8 | |
| GLTLSPEQGTNEKSN | 456 | Q9UNY4 | |
| SEKLFNTPTENGSLG | 1131 | O75132 | |
| QTPFAGTQDKSSLVG | 2736 | O14686 | |
| GKASLSPSSINQNFP | 2081 | Q5VU43 | |
| PLSISGNFSLKQDGS | 256 | Q9HD90 |